Content of CYTOCON DB:

• 523 disease types, press to view details;

  • Acinic cell adenocarcinoma, press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)

  • Acromegaly, press to view attributes;

    • SAGIT

  • Acute allergic reactions, press to view attributes;

    • Severity score for acute allergic reactions
  • Acute coronary syndrome
  • Acute coronary syndrome, nonocclusive type (unstable angina)
  • Acute coronary syndrome, occlusive type (transmural myocardial infarction)
  • Acute disseminated encephalomyelitis (ADEM)
  • Acute hepatitis A

  • Acute hepatitis B, press to view attributes;

    • Anti-HBe seropositivity
    • Child–Pugh stage
    • Disease duration
    • HBcAb seropositivity
    • HBeAg seropositivity
    • HBsAb seropositivity
    • HBsAg seropositivity
    • Period of infection disease
  • Acute hepatitis C

  • Acute lymphoblastic leukemia, press to view attributes;

    • Stage
  • Acute lymphoid leukaemia
  • Acute lymphoma
  • Acute myeloblastic leukemia

  • Acute myeloid leukaemia, press to view attributes;

    • ECOG status
    • FAB classification subtype

  • Acute pancreatitis, press to view attributes;

    • % of deaths
    • APACHE II score
    • Balthazar score
    • BISAP score
    • Glasgow severity score
    • MCTSI score
    • Ranson score
    • Severity
    • SOFA (Sepsis-related organ failure assessment score)
  • Acute pyelonephritis

  • Acute-on-chronic liver failure, press to view attributes;

    • Anti-HBe seropositivity
    • Clinical outcome
    • HBeAg seropositivity
    • HBsAb seropositivity
    • MELD score

  • Adenocarcinoma of bronchus or lung, press to view attributes;

    • Cancer stage (I-IV)
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
  • Adenocarcinoma of cervix

  • Adenocarcinoma of oesophagus, press to view attributes;

    • Cancer stage (I-IV)
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
    • Tumor differentiation
  • Adenocarcinoma of stomach

  • Adenoid cystic carcinoma, press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
  • Adenosquamous carcinoma of bronchus or lung

  • Adult dermatomyositis, press to view attributes;

    • Anti–Jo-1 seropositivity
    • Antinuclear antibody (ANA)-positivity
    • Physician global assessment VAS

  • Adult non-specific myositis and overlap myositis, press to view attributes;

    • Disease duration
  • Adult T-cell leukaemia/lymphoma (ATLL)

  • Adult-onset Still’s disease (AOSD), press to view attributes;

    • Disease activity
    • Disease duration
    • HAQ score
    • Patient/parent general VAS
    • Physician global assessment VAS
    • Swollen joint count
    • Tender joint count (TJC)
    • VAS-PAIN
  • Aggressive periodontitis
  • AIDS

  • AIDS-related non-Hodgkin lymphoma, press to view attributes;

    • Histology type

  • Alcohol-induced dementia, press to view attributes;

    • Mini Mental State Examination (MMSE)
  • Alcoholism

  • Allergic asthma, press to view attributes;

    • PD20 methacholine
    • Wheal diameter induced by allergen (mm)
  • Allergic contact dermatitis

  • Allergic rhinitis, press to view attributes;

    • Disease duration
    • FEV1, % predicted
    • PD20 methacholine
    • Severity
    • Total Nasal Symptom Score (TNSS)
    • Wheal diameter induced by allergen (mm)

  • Alpha-1-antitrypsin deficiency, press to view attributes;

    • AAT genotype
    • APRI
    • CAT score
    • DLCOc (% predicted)
    • FEV1, % predicted
    • FEV1, L
    • FEV1/FVC
    • FEV1/FVC (% predicted)
    • FVC (% predicted)
    • FVC, L
    • GOLD classification
    • HepaScore
    • HRCT grading of emphysema
    • Liver stiffness (kPa)
    • Maximal mid-expiratory flow (MMEF)
    • MEF25
    • MEF50
    • MEF75
    • PEF (peak expiratory flow rate)
    • Residual volume (%)
    • Residual volume (L)
    • SpO2 (oxygen saturation) %
    • TLC (% predicted)
    • TLC (L)
  • Alveolar rhabdomyosarcoma
  • Alveolar soft part sarcoma

  • Alzheimer disease, press to view attributes;

    • APOE4 status
    • Clinical dementia rating (CDR)
    • Disease duration
    • Mini Mental State Examination (MMSE)
  • Amplified pain syndrome

  • Ampullary cancer, press to view attributes;

    • Histology type

  • Anaplastic large cell lymphoma ALK-, press to view attributes;

    • Ann Arbor stage
    • Performance status (ECOG/WHO)

  • Aneurysmal Subarachnoid Hemorrhage, press to view attributes;

    • Aneurysmal diameter
    • Modified Fisher score (MFS)
    • Severity
    • WFNS grade (World Federation of Neurological Surgeons)

  • Angioimmunoblastic T-cell lymphoma, press to view attributes;

    • Ann Arbor stage
    • Performance status (ECOG/WHO)
  • Angiosarcoma

  • Ankylosing spondylitis, press to view attributes;

    • ASDAS
    • BASDAI
    • BASFI
    • BASMI
    • Disease duration
    • HLA-B27 seropositivity

  • Antiphospholipid syndrome, press to view attributes;

    • Anti-ds-DNA positivity
    • Antinuclear antibody (ANA)-positivity
    • Disease duration
    • Rheumatoid factor (RF) seropositivity

  • Aplastic anemia, press to view attributes;

    • % of deaths
    • Disease duration
    • ECOG status
    • Severity
  • Appendicitis and Diverticulitis

  • Asthma, press to view attributes;

    • % reversibility
    • Aas score
    • ACQ
    • ACQ-5 score
    • ACQ-6 score
    • ACQ-7 score
    • Airway resistance
    • AM asthma symptom score
    • AQLQ global score
    • Asthma control test (ACT) score
    • Asthma status
    • Atopy
    • Average daily symptom score
    • Daily dose of ICS
    • DASH Score
    • Disease duration
    • FEF 25-75 (% predicted)
    • FEF 25-75 (L/sec)
    • FeNO
    • FEV1 (L/min)
    • FEV1 after salbutamol (% predicted)
    • FEV1 before salbutamol (% predicted)
    • FEV1 reversibility, %
    • FEV1, % predicted
    • FEV1, L
    • FEV1/FVC
    • FVC (% predicted)
    • FVC, L
    • Global Initiative for Asthma (GINA)
    • HADS‐A
    • HADS‐D
    • IgE total
    • Maximal mid-expiratory flow (MMEF)
    • Modified Borg Scale scores
    • Number of exacerbations per year
    • Patient # on ICS
    • PC20 after methacholine
    • PEF (peak expiratory flow rate)
    • Phase
    • PM asthma symptom score
    • Severity
    • TLC (% predicted)
  • Asthma, food allergy and atopic dermatitis

  • Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS), press to view attributes;

    • FEV1, % predicted
    • FEV1, L
    • Phase

  • Asymptomatic HBV carriers, press to view attributes;

    • Anti-HBe seropositivity
    • HBcAb seropositivity
    • HBsAb seropositivity
  • Atopic allergy
  • Atopic asthma

  • Atopic dermatitis, press to view attributes;

    • AD phase
    • AD type
    • CDLQI - Children’s Dermatology Life Quality Index
    • Disease duration
    • EASI
    • Extent (%) - affected Body Surface Area (BSA))
    • IGA
    • IgE specific
    • IgE total
    • oSCORAD
    • Pruritus (VAS)
    • Pruritus score
    • SCORAD
    • Severity
    • SH (Skin Hydration)
    • Sleep loss
    • TEWL
    • VAS

  • Atopy, nonasthma, press to view attributes;

    • FEV1, % predicted
    • FEV1, L
    • PC20 after methacholine
  • Atrial fibrillation
  • Atypical autism (F84.1)
  • Atypical hyperplasia
  • Autism (F84.0)
  • Autism spectrum disorder
  • Autoimmune gastritis

  • Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, press to view attributes;

    • EDSS score
    • Modified Rankin Scale

  • Autoimmune hemolytic anemia, press to view attributes;

    • Antinuclear antibody (ANA)-positivity

  • Autoimmune hepatitis, press to view attributes;

    • Activity of inflammation
    • Antinuclear antibody (ANA)-positivity
    • Anti-SMA seropositivity
    • Fibrosis stage
    • IAIHG criteria score
  • Autoimmune pancreatitis
  • B chronic lymphocytic leukemia
  • Bacterial infections

  • Bacterial meningitis, press to view attributes;

    • Disease duration

  • Bacterial pneumonia, press to view attributes;

    • Severity
  • Bacterial sepsis-ARDS
  • Basal cell carcinoma

  • B-cell acute lymphoblastic leukemia, press to view attributes;

    • Minimal residual disease (MRD)
  • B-cell non-Hodgkin lymphoma (B-NHL)
  • B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

  • Behçet's disease, press to view attributes;

    • Disease duration
    • HLA-B51 seropositivity
    • Stage
    • The Behcet’s Disease Current Activity Form (BDCAF) transformed index
  • Benign bone tumors
  • Benign conditions of ovary and uterus
  • Benign head and neck diseases
  • Benign lung diseases

  • Benign lung lesions, press to view attributes;

    • Disease duration
  • Benign ovarian pathologies
  • Benign prostatic hyperplasia
  • Benign pulmonary diseases
  • Benign pulmonary nodules
  • Benign reactive lymphoid hyperplasia
  • Benign soft-tissue neoplasm
  • Benign tumour of lung

  • Beta-thalassaemia, press to view attributes;

    • TSAT (transferrin saturation)
  • Beta-thalassaemia intermedia
  • Beta-thalassaemia major

  • Bladder cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • Histological grade
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
  • Brain trauma
  • Breast benign tumor

  • Breast cancer, press to view attributes;

    • % of deaths
    • Cancer stage (I-IV)
    • Clinical outcome
    • Disease duration
    • ECOG status
    • ER status
    • Her2 expression
    • Histological grade
    • Histology type
    • Lymph node metastasis
    • Lymphovascular space invasion (LVSI)
    • M stage of cancer (TNM)
    • Molecular subtype
    • N stage of cancer (TNM)
    • PR expression
    • Severity
    • T stage of cancer (TNM)
    • TIL PD-L1 expression
    • Tumor cell PD-L1 expression
    • Tumor size (cm)
    • Tumor type
    • WHO grade
  • Breast carcinoma
  • Breast ductal carcinoma
  • Bronchial asthma

  • Bronchiectasis, press to view attributes;

    • Disease duration
    • FEV1 after salbutamol (% predicted)
    • FEV1, L
  • Bronchioalveolar adenocarcinoma

  • Bronchiolitis, press to view attributes;

    • Phase
  • Bronchoalveolar carcinoma

  • Bullous pemphigoid, press to view attributes;

    • BP180-NC16A
    • BP230-CF
    • BPDAI Blisters/erosions score
    • BPDAI Erythema/urticaria score
    • BPDAI score
    • BPDAI skin activity score
    • Disease duration
    • Number of lesions
    • Pruritus score
    • Severity
    • Stage

  • Burns, press to view attributes;

    • % of deaths
  • Carcinoma
  • CD40L deficiency
  • Celiac disease
  • Central nervous system infection

  • Cerebrovascular disease no-dementia, press to view attributes;

    • Mini Mental State Examination (MMSE)

  • Cervical cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • FIGO stage of UCC
    • Histological grade
    • Histology type
    • HPV-positivity
    • Lymph node metastasis
    • Lymphovascular space invasion (LVSI)
    • Severity
    • Tumor size
  • Cervical carcinoma

  • Cervical intraepithelial neoplasia, press to view attributes;

    • Cancer stage (I-IV)
    • HPV-positivity
  • Chest infections
  • Chondrosarcoma
  • Chordoma
  • Chronic atrophic gastritis
  • Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE)
  • Chronic Bronchial Asthma

  • Chronic bronchitis (COPD), press to view attributes;

    • FEV1 after salbutamol (% predicted)
    • FEV1 before salbutamol (% predicted)
  • Chronic calculous cholecystitis

  • Chronic cholecystitis, press to view attributes;

    • Phase

  • Chronic cough, press to view attributes;

    • FEV1, % predicted
  • Chronic hepatitis

  • Chronic hepatitis B, press to view attributes;

    • Activity of inflammation
    • Anti-HBe seropositivity
    • Clinical outcome
    • Disease duration
    • Fibrosis score
    • Fibrosis stage
    • HBcAb seropositivity
    • HBcAg Expression Patterns in Hepatocyte
    • HBeAg seropositivity
    • HBsAb seropositivity
    • HBsAg Expression Patterns in Hepatocyte
    • HBsAg seropositivity
    • HBV genotype
    • Histological activity index
    • Inflammation grade
    • Ishak grading total
    • Ishak staging
    • Knodell histologic activity index
    • MELD score
    • parenchymal liver disease (PLD) score
    • Period of infection disease
    • Phase
    • Severity

  • Chronic Hepatitis C, press to view attributes;

    • APRI
    • Disease duration
    • FIB-4
    • Fibrosis score
    • Fibrosis stage
    • HCV genotype
    • HCV serology
    • IgM-Rheumatoid factor seropositivity
    • Inflammation grade
    • Inflammatory activity grade
    • Ishak staging
    • Knodell histologic activity index
    • Period of infection disease
  • Chronic idiopathic urticaria, hives

  • Chronic kidney disease, press to view attributes;

    • Stage

  • Chronic liver failure (CLF), press to view attributes;

    • HBsAg seropositivity

  • Chronic lymphocytic leukemia, press to view attributes;

    • Clinical form
    • Disease duration
  • Chronic myelogenous leukemia
  • Chronic myeloid leukaemia

  • Chronic myelomonocytic leukemia (MDS-CMML), press to view attributes;

    • FAB subtypes
    • IPSS risk stratification
    • TSAT (transferrin saturation)
  • Chronic obstructive bronchitis

  • Chronic obstructive pulmonary disease (COPD), press to view attributes;

    • AAT genotype
    • Atopy
    • BODE Index
    • CAT score
    • CMI (Charlson Comorbidity Index)
    • Disease duration
    • DLCOc (% predicted)
    • FEV1, % predicted
    • FEV1, L
    • FEV1/FVC
    • FEV1/FVC (% predicted)
    • FVC (% predicted)
    • FVC, L
    • GOLD
    • GOLD classification
    • HRCT grading of emphysema
    • MEF25
    • MEF50
    • MEF75
    • mMRC score
    • PEF (peak expiratory flow rate)
    • Phase
    • Residual volume (%)
    • Residual volume (L)
    • Severity
    • TLC (% predicted)
    • TLC (L)

  • Chronic pancreatitis, press to view attributes;

    • Disease duration
  • Chronic recurrent multifocal osteomyelitis
  • Chronic Spontaneous Urticaria
  • Chronic superficial gastritis
  • Clear cell sarcoma
  • Clinically isolated syndrome
  • Clonal cytopenia of undetermined significance (CCUS)

  • Coeliac disease, press to view attributes;

    • Endomysium antibodies seropositivity
    • IgA class R1-type reticulin seropositivity
    • Marsh score

  • Colitis, press to view attributes;

    • Disease duration
  • Colitis associated cancer (CAC)
  • Collagenous colitis
  • Colon adenocarcinoma
  • Colon carcinoma
  • Colonic cancer

  • Colorectal cancer (CRC), press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Clinical outcome
    • Disease duration
    • ECOG status
    • Histological grade
    • Histological score
    • Liver metastases
    • Localization of the disease
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
    • Tumor differentiation
    • Tumor site/location
    • Tumor size (cm)
    • WHO grade
  • Colorectal carcinoma
  • Colorectal polyp

  • Common variable immunodeficiency (CVID), press to view attributes;

    • Disease duration
  • Community acquired pneumonia

  • Congenital sideroblastic anaemia, press to view attributes;

    • UIBC
  • Contact dermatitis

  • COVID-19, press to view attributes;

    • % of deaths
    • APACHE II score
    • ARDS-Berlin score severity
    • Cancer stage (I-IV)
    • Charlson Index
    • Clinical outcome
    • CT score
    • DASO (Days after symptom onset)
    • Disease duration
    • ECOG status
    • Elixhauser Index
    • Histological grade
    • HScore
    • NEWS (National Early Warning Score)
    • NIH Ordinal Scale
    • PSI (pneumonia severity index)
    • SAPS, simplified acute physiology score
    • SARS-COV2 confirmed by PCR (%)
    • SARS-CoV-2 IgG antibodies
    • Severity
    • SOFA (Sepsis-related organ failure assessment score)
    • SpO2 (oxygen saturation) %
    • WHO score
  • COVID-19 pneumonia

  • Crohn's disease, press to view attributes;

    • Clinical activity index (HBI)
    • Clinical form
    • Crohn’s Disease Activity Index (CDAI)
    • Crohn’s Disease Endoscopic Index of Severity (CDEIS)
    • Disease activity
    • Disease duration
    • Endoscopic activity score (Rutgeerts)
    • Harvey-Bradshaw Index (HBI) Score
    • Histological score
    • Index of inflammatory bowel disease (IOIBD)
    • Localization of the disease
    • Montreal age
    • Montreal Behavior
    • Montreal Location
    • PCDAI (pediatric Crohn's disease activity index)
    • Phase
    • SES-CD
    • Severity
    • Simple Endoscopy Severity (SES)
    • Stage
  • Cutaneous Lupus Erythematosus
  • Cutaneous squamous cell carcinoma

  • Cutaneous T-cell lymphoma, press to view attributes;

    • Cancer stage (I-IV)
  • Cyclic neutropenia

  • Cystic fibrosis, press to view attributes;

    • FEV1, % predicted
    • FVC (% predicted)
    • Severity
    • TLC (% predicted)
  • Dedifferentiated liposarcoma
  • Deep vein thrombosis

  • Dementia with Lewy bodies (DLB), press to view attributes;

    • Disease duration
    • Mini Mental State Examination (MMSE)
  • Dengue

  • Depression (6A70.Z Single episode depressive disorder), press to view attributes;

    • 16-HDRS
    • Beck Depression Inventory (BDI)
    • BPQ
    • Clinical form
    • Mini Mental State Examination (MMSE)
  • Dermatitis herpetiformis

  • Dermatomyositis, press to view attributes;

    • Disease duration
    • Stage
  • Dermatophytosis
  • Desmoplastic small round cell tumour
  • DFSP dermatofibrosarcoma protuberans
  • Diffuse large B-cell lymphoma

  • Diffuse Large-cell lymphoma, press to view attributes;

    • Ann Arbor stage
    • B symptoms present
    • International Index score
    • Serum lactate dehydrogenase level
    • Serum level of beta2-microglobulin
  • Discoid Lupus Erythematosus

  • DOCK8 deficiency, press to view attributes;

    • SCORAD
    • VAS
  • Dysbacteriosis
  • Dysmyelopoiesis
  • Early arthritis
  • Embryonal rhabdomyosarcoma
  • Encephalitis
  • End stage renal disease
  • Endometrial carcinoma

  • Endometriosis, press to view attributes;

    • Phase of the menstrual cycle
    • rASRM stage
  • End-stage kidney disease
  • End-stage renal failure
  • Enterohaemorrhagic Escherichia coli infection

  • Enthesitis-related arthritis, press to view attributes;

    • Disease duration
  • Eosinophilia

  • Eosinophilic asthma, press to view attributes;

    • ACQ-6 score
    • Atopy
    • FEV1 after salbutamol (% predicted)
    • FEV1, % predicted
    • FVC (% predicted)
    • Severity

  • Eosinophilic bronchitis, press to view attributes;

    • FEV1, % predicted
    • PC20 after methacholine

  • Eosinophilic fasciitis, press to view attributes;

    • Disease duration
    • mLoSSI (modified Localized Scleroderma Skin Score)
    • VAS
  • Epithelioid sarcoma
  • Epstein-Barr virus (EBV) infection
  • Erythema multiforme

  • Esophageal cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • Histological grade
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
    • TEWL

  • Esophageal carcinoma, press to view attributes;

    • Cancer stage (I-IV)
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
    • Tumor site/location
  • Ewing sarcoma
  • Familial lecithin:cholesterol acyltransferase (LCAT) deficiency
  • Familial lipoprotein lipase (LPL) deficiency
  • Fanconi anaemia
  • Farber disease
  • Fatty liver disease
  • Fibromyalgia
  • Fibrotic hypersensitivity pneumonitis
  • Focal segmental glomerulosclerosis
  • Follicular lymphoma
  • Food allergy and atopic dermatitis

  • Frontotemporal lobe dementia (FTLD), press to view attributes;

    • Mini Mental State Examination (MMSE)
  • Gallbladder cancer
  • Gallbladder dysplasia
  • Gastric adenocarcinoma

  • Gastric cancer, press to view attributes;

    • % of deaths
    • Bormann type
    • Cancer stage (I-IV)
    • Clinical outcome
    • Distant metastasis
    • ECOG status
    • H. pylori antibody
    • Her2 expression
    • Histological grade
    • Histology type
    • Localization of the disease
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
    • Tumor size
    • Tumor size (cm)
  • Gastric ulcer
  • Gaucher disease
  • Giant cell arteritis

  • GIST gastrointestinal stromal tumour, press to view attributes;

    • Cancer stage (I-IV)
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
  • Gliosarcoma

  • Gout, press to view attributes;

    • Disease duration

  • Graves disease, press to view attributes;

    • Disease duration
    • Goiter degree
    • GREAT score
    • GREAT score classes
    • Ophthalmopathy
  • Guillain–Barre syndrome
  • Haemoglobin E beta-thalassaemia

  • Hashimoto's thyroiditis, press to view attributes;

    • Disease duration
    • HOMA score (Homeostatic model assessment)
    • Ophthalmopathy

  • HBV carriers, press to view attributes;

    • Fibrosis stage
    • HBeAg seropositivity
    • HBsAg seropositivity
    • Inflammation grade

  • HBV-related cirrhosis, press to view attributes;

    • Child–Pugh stage
    • HBeAg seropositivity
    • Phase

  • HBV-related HCC (hepatocellular carcinoma), press to view attributes;

    • Cancer stage (I-IV)

  • Head and neck cancer, press to view attributes;

    • Cancer stage (I-IV)
    • ECOG status
    • Histology type
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
    • Tumor differentiation
    • Tumor site/location

  • Head and Neck Squamous Cell Carcinoma, press to view attributes;

    • % of deaths
    • Cancer stage (I-IV)
    • Disease duration
    • EBV DNA seropositivity
    • ECOG status
    • Histological grade
    • HPV-positivity
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
    • Tumor differentiation
    • Tumor site/location

  • Healthy control, press to view attributes;

    • AAT genotype
    • Anti-dsDNA
    • Antinuclear antibody (ANA)-positivity
    • Anti-SMA seropositivity
    • APACHE II score
    • APOE4 status
    • APRI
    • ASA
    • Atopy
    • BODE Index
    • BPQ
    • CAT score
    • Clinical dementia rating (CDR)
    • CMI (Charlson Comorbidity Index)
    • Depressive symptoms (MFQ-C)
    • DLCOc (% predicted)
    • EBV DNA seropositivity
    • ELF score (enhanced liver fibrosis)
    • Endomysium antibodies seropositivity
    • FEF 25-75 (% predicted)
    • FEF 25-75 (L/sec)
    • FeNO
    • FEV1 after salbutamol (% predicted)
    • FEV1 before salbutamol (% predicted)
    • FEV1, % predicted
    • FEV1, L
    • FEV1/FVC
    • FSS (Fatigue Severity Scale)
    • FVC (% predicted)
    • FVC, L
    • HbA1c level
    • HBsAg seropositivity
    • HCV serology
    • HepaScore
    • HOMA score (Homeostatic model assessment)
    • HOMA%B
    • HOMA%S
    • HOMA2IR
    • HPV-positivity
    • IgA class R1-type reticulin seropositivity
    • IgE total
    • IgG index
    • Karnofsky performance status
    • Liver stiffness (kPa)
    • Maximal mid-expiratory flow (MMEF)
    • MEF25
    • MEF50
    • MEF75
    • Metabolic syndrome (IDF criteria)
    • Mini Mental State Examination (MMSE)
    • PC20 after methacholine
    • PEF (peak expiratory flow rate)
    • Performance status (ECOG/WHO)
    • Phase of the menstrual cycle
    • Residual volume (%)
    • SpO2 (oxygen saturation) %
    • STAI State
    • STAI Total anxiety
    • STAI Trait
    • TLC (% predicted)
    • Total iron-binding capacity (TIBC)
    • TSAT (transferrin saturation)
    • UIBC
  • Hemolytic anemia

  • Hepatitis B, press to view attributes;

    • Child–Pugh stage
    • HBeAg seropositivity
    • Knodell histologic activity index
    • Phase
  • Hepatitis C
  • Hepatitis non-infectious

  • Hepatocellular carcinoma (HCC), press to view attributes;

    • BCLC stage
    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Child–Pugh stage
    • Clinical outcome
    • CLIP score
    • Distant metastasis
    • ECOG status
    • HAI score
    • HBeAg seropositivity
    • HBsAg seropositivity
    • HCV serology
    • HCV-Ab seropositivity
    • Histological grade
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Number of tumors
    • Okuda staging system
    • Severity
    • T stage of cancer (TNM)
    • Tumor size (cm)
    • Up-to-7 criteria
    • Vasoinvasion

  • Hereditary spherocytosis, press to view attributes;

    • TSAT (transferrin saturation)

  • Hereditary xerocytosis, press to view attributes;

    • TSAT (transferrin saturation)

  • HIV infection, press to view attributes;

    • APRI
    • Disease duration
    • FIB-4
    • Fibrosis stage
    • HBeAg seropositivity
    • HBsAg seropositivity
    • HIV-infection stage
    • Ishak staging
  • HIV-1-associated dementia

  • Hodgkin's lymphoma, press to view attributes;

    • Ann Arbor stage
    • B symptoms present
    • Histology
    • Histology type
    • Serum lactate dehydrogenase level
    • Serum level of beta2-microglobulin

  • Human immunodeficiency virus (HIV-1) infection, press to view attributes;

    • HIV-RNA in blood
    • HIV-RNA in CSF
    • HOMA score (Homeostatic model assessment)
  • Human immunodeficiency virus (HIV-2) infection
  • Hyperuricemia
  • Hypopharyngeal squamous cell carcinoma
  • Idiopathic aplastic anemia
  • Idiopathic cytopenia of undetermined significance (ICUS)
  • Idiopathic inflammatory myopathies

  • Idiopathic interstitial pneumonia, press to view attributes;

    • FEV1, % predicted
  • Idiopathic membranous nephropathy
  • Idiopathic pulmonary fibrosis
  • IgA-deficiency disorder

  • IgG4-related disease, press to view attributes;

    • Antinuclear antibody (ANA)-positivity
    • Clinical form
    • Disease duration
    • ELF score (enhanced liver fibrosis)
    • IgG4-RD RI (Responder Index)
    • Number of organs involved
    • Physician Global Assessment (PGA)
    • Rheumatoid factor (RF) seropositivity
  • Immune aplastic anemia

  • Immune thrombocytopenia, press to view attributes;

    • Anti-Glycoprotein (anti-GP) autoantibody
    • Bleeding grade
    • Buchanan score
    • Clinical form
    • Disease duration
    • Severity
  • Immune thrombocytopenic purpura
  • Immune-checkpoint inhibitor-associated pneumonitis
  • Immunoglobulin (Ig)G subclass-deficiency

  • Immunoglobulin A nephropathy (IgAN), press to view attributes;

    • Histological grading

  • Infection of high-risk human papillomavirus (HPV), press to view attributes;

    • HPV-positivity

  • Infections, press to view attributes;

    • % of deaths
    • CMI (Charlson Comorbidity Index)
    • qSOFA (quick Sequential Organ Failure Assessment)
    • SOFA (Sepsis-related organ failure assessment score)
  • Infectious colitis

  • Inflammatory Bowel Diseases, press to view attributes;

    • Clinical activity index (HBI)
    • Clinical activity index (Mayo)
    • Disease duration
    • Endoscopic activity score (Mayo)
    • Endoscopic activity score (Rutgeerts)
    • Endoscopic severity (Mayo)
    • Harvey-Bradshaw Index (HBI) Score
    • Localization of the disease
    • PCDAI (pediatric Crohn's disease activity index)
    • PUCAI (pediatric ulcerative colitis activity index)
    • Simple Endoscopy Severity (SES)
    • Stage
  • Inflammatory breast cancer (IBC)
  • Inflammatory skin diseases

  • Influenza, press to view attributes;

    • % of deaths
    • % reversibility
    • Severity
    • SOFA (Sepsis-related organ failure assessment score)

  • Influenza A (H1N1), press to view attributes;

    • % of deaths
    • APACHE II score
    • SOFA (Sepsis-related organ failure assessment score)

  • Interstitial lung diseases, press to view attributes;

    • DLCOc (% predicted)
    • FEV1, % predicted
    • FVC (% predicted)
    • TLC (% predicted)
  • Interstitial pneumonia with autoimmune features
  • Iron deficiency anaemia
  • Irritable Bowel Syndrome

  • Ischemic stroke, press to view attributes;

    • NIHSS
  • Juvenile chronic arthritis

  • Juvenile dermatomyositis, press to view attributes;

    • Anti–Jo-1 seropositivity
    • Antinuclear antibody (ANA)-positivity
    • CMAS (Childhood Myositis Assessment Scale)
    • DAS muscle
    • DAS skin
    • DAS total
    • Disease duration
    • MMT-8 score
    • MSA seropositivity (Myositis-specific antibodies)
    • Physician global assessment VAS
  • Juvenile enthesitis related arthritis

  • Juvenile idiopathic arthritis, press to view attributes;

    • Active joint count
    • Anti-CCP antibody [ACPA] positivity
    • Antinuclear antibody (ANA)-positivity
    • C-HAQ (Childhood Health Assessment Questionnaire)
    • CHAQ disability index
    • CHAQ pain visual analogue score
    • Clinical form
    • DAS28
    • Depressive symptoms (MFQ-C)
    • Disease activity
    • Extent of joints involvement
    • FEV1, % predicted
    • FEV1/FVC
    • FVC (% predicted)
    • HLA-B27 seropositivity
    • HOMA score (Homeostatic model assessment)
    • HRQoL (0–30)
    • JADAS10 score
    • JADAS-27
    • JADAS3
    • JADAS-71
    • JSpaDA score
    • Limited/restricted joint count
    • mJSpADA-CRP (6)
    • mJSpADA-ESR (6)
    • MSMS (systemic)
    • Patient/parent general VAS
    • PF score (0–45)
    • Ph activity (0–10)
    • Physician global assessment VAS
    • PW VAS (0–10)
    • Rheumatoid factor (RF) seropositivity
    • STAI State
    • STAI Total anxiety
    • STAI Trait
    • Swollen joint count (66-joint score)
    • Tender joint count (68-joint score)
    • VAS-PAIN

  • Juvenile rheumatoid arthritis, press to view attributes;

    • Stage

  • Kawasaki disease, press to view attributes;

    • Stage
  • Kidney cancer
  • Kikuchi-Fujimoto disease

  • Knee osteoarthritis, press to view attributes;

    • Severity
  • Langerhans cell histiocytosis
  • Large cell carcinoma of bronchus or lung
  • Laryngeal papilloma
  • Laryngeal Squamous Cell Carcinoma
  • Latent autoimmune diabetes in adults
  • Leiomyosarcoma

  • Lichen planus, press to view attributes;

    • Oral lichen planus type

  • Liver cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • Histological grade
    • Severity

  • Liver cirrhosis, press to view attributes;

    • Child–Pugh stage
    • HBeAg seropositivity
    • HBsAg seropositivity
    • MELD score
  • Liver hemangioma

  • Localized scleroderma, press to view attributes;

    • AHA seropositivity
    • Antinuclear antibody (ANA)-positivity
    • anti-ssDNA seropositivity
    • CDLQI - Children’s Dermatology Life Quality Index
    • Disease activity
    • Disease duration
    • LoSDI (Localized Scleroderma Damage Index)
    • mLoSSI (modified Localized Scleroderma Skin Score)
    • Parent Global Assessment of disease impact
    • Patient Global Assessment of disease impact
    • PGA-A (Physician global assessment of activity)
    • PGA-D (Physician Global Assessment of Damage)
    • Physician Global Assessment (PGA)
    • VAS
  • Low-grade fibromyxoid sarcoma

  • Lung adenocarcinoma, press to view attributes;

    • Distant metastasis
    • Histology type

  • Lung cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • Disease duration
    • Distant metastasis
    • ECOG status
    • FEV1, % predicted
    • Histological grade
    • Histology type
    • Karnofsky performance status
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Performance status (ECOG/WHO)
    • Severity
    • T stage of cancer (TNM)
    • Tumor size (cm)
    • Tumor type
  • Lung squamous cell carcinoma

  • Lupus nephritis, press to view attributes;

    • AI (activity index)
    • ANA titer
    • Anti-dsDNA
    • Anti-ds-DNA positivity
    • Antinuclear antibody (ANA)-positivity
    • Anti-Phospholipids seropositivity
    • anti-RNP seropositivity
    • Chronicity index (CI)
    • Disease duration
    • Glomerulonephritis class
    • ISN/RPS (International Society of Nephrology/Renal Pathology Society) class
    • Non-renal SLEDAI
    • Positivity of anti-Sm
    • Positivity of anti-SSA/SSB
    • SLEDAI
    • SLEDAI 2K
    • Stage
    • WHO Class

  • Lyme neuroborreliosis, press to view attributes;

    • Disease duration
  • Lymphadenopathic mastocytosis with eosinophilia
  • Lymphocytic colitis
  • Lymphoid neoplasm
  • Macrophage activation syndrome

  • Major depressive disorder, press to view attributes;

    • Disease duration
    • HAMA score
    • HAMD score
  • Malignant bone tumors
  • Malignant melanoma

  • Malignant salivary gland tumors, press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)

  • Mantle cell lymphoma, press to view attributes;

    • Ann Arbor stage
    • B symptoms present
    • ECOG status
  • Mastocytosis

  • Melanoma, press to view attributes;

    • % of deaths
    • Breslow score
    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Clark's level
    • Distant metastasis
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
  • Metabolic Syndrome
  • Metaplastic breast carcinoma
  • Microcrystal arthritis

  • Mild cognitive impairment (MCI), press to view attributes;

    • Mini Mental State Examination (MMSE)

  • Mild cognitive impairment with Alzheimer’s disease (MCI-AD), press to view attributes;

    • Mini Mental State Examination (MMSE)

  • Mild cognitive impairment with Lewy body dementia (MCI-LB), press to view attributes;

    • Mini Mental State Examination (MMSE)
  • Minimal change disease (MCD, minimal change glomerulopathy)

  • Mixed connective tissue disease, press to view attributes;

    • Disease duration
    • SLEDAI
  • Mixed germ cell tumor
  • Mixed granulocytic asthma
  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Morbidly obese
  • MPNST malignant peripheral nerve sheath tumor

  • Mucoepidermoid carcinoma, press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)

  • Multiple myeloma, press to view attributes;

    • Bone Lesion Score
    • Cancer stage (I-IV)
    • Disease duration
    • Durie-Salmon stage
    • ISS stage
    • WHO grade

  • Multiple sclerosis, press to view attributes;

    • Beck Depression Inventory (BDI)
    • Blood-Brain Barrier impairment
    • CIS20r Concentration
    • CIS20r Fatigue
    • CIS20r Motivation
    • CIS20r Physical activity
    • Clinical form
    • Disease duration
    • EDSS score
    • IgG index
    • MSIS-29 physical
    • MSIS-29 psychological
    • MSSS (multiple sclerosis severity score)
    • Number of relapses (attacks)
    • Oligoclonal bands (OCB)
    • Phase
    • SDMT
    • Severity
    • STAI State
    • STAI Trait
  • Multisystem inflammatory syndrome associated with COVID-19

  • Multisystem inflammatory syndrome in children (MIS-C), press to view attributes;

    • HScore
    • SARS-COV2 confirmed by PCR (%)
    • SARS-CoV-2 IgG antibodies
    • Severity

  • Myasthenia gravis, press to view attributes;

    • AChR-Ab titer
    • Anti-AChR-Ab seropositivity
    • Disease duration
    • MGADL score
    • MGFA severity
    • Osserman Class
  • Mycosis fungoides

  • Myelodysplastic syndrome, press to view attributes;

    • % of deaths
    • Disease duration
    • FAB subtypes
    • FEV1, % predicted
    • FEV1/FVC
    • FSS (Fatigue Severity Scale)
    • FVC (% predicted)
    • IPSS risk stratification
    • IPSS-R (Revised International Prognostic Scoring System)
    • IPSS-R risk stratification
    • IPSS-RA
    • Severity
    • SpO2 (oxygen saturation) %
    • Total iron-binding capacity (TIBC)
    • TSAT (transferrin saturation)
    • WHO subgroups
    • WPSS risk group

  • Myelodysplastic syndrome Refractory anaemia with excess blasts (MDS-RAEB), press to view attributes;

    • FAB subtypes

  • Myelodysplastic syndrome Refractory anaemia with excess blasts in transformation (MDS-RAEB-t)), press to view attributes;

    • FAB subtypes
    • IPSS risk stratification
    • TSAT (transferrin saturation)

  • Myelodysplastic syndrome refractory anemia, press to view attributes;

    • FAB subtypes
    • IPSS risk stratification
    • TSAT (transferrin saturation)

  • Myelodysplastic syndrome refractory anemia with ring sideroblasts (MDS-RS), press to view attributes;

    • % of deaths
    • FAB subtypes
    • IPSS risk stratification
    • TSAT (transferrin saturation)
    • UIBC
    • WHO subgroups

  • Myelodysplastic syndrome refractory cytopenia with multilineage dysplasia, press to view attributes;

    • IPSS risk stratification
    • TSAT (transferrin saturation)
    • UIBC

  • Myelodysplastic syndrome with excess blasts, press to view attributes;

    • FAB subtypes
    • IPSS risk stratification
    • Severity
    • TSAT (transferrin saturation)

  • Myelodysplastic syndrome with isolated del (5q), press to view attributes;

    • IPSS risk stratification
    • TSAT (transferrin saturation)

  • Myelodysplastic/myeloproliferative diseases, press to view attributes;

    • IPSS risk stratification
    • TSAT (transferrin saturation)
  • Myelofibrosis
  • Myelomonocytic leukemia
  • Myeloproliferative neoplasms
  • Myoma
  • Myxofibrosarcoma
  • Myxoid/round cell liposarcoma (MRCL)

  • Nasopharyngeal carcinoma (NPC), press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • Histological grade
    • Severity
  • Nasopharyngeal squamous cell carcinoma
  • Neonatal-onset multisystem inflammatory disease (NOMID)
  • Neuroblastoma

  • Neurologic diseases, press to view attributes;

    • Blood-Brain Barrier impairment
    • Disease duration

  • Neuromyelitis optica, press to view attributes;

    • anti-AQP4 antibody seropositivity
    • Clinical form
    • EDSS score
    • IgG index

  • Neuromyelitis optica spectrum disorder, press to view attributes;

    • anti-AQP4 antibody seropositivity
    • Disease duration
    • EDSS score

  • Neurosyphilis, press to view attributes;

    • Disease duration

  • Neutrophilic asthma, press to view attributes;

    • ACQ-6 score
    • Atopy
    • FEV1 after salbutamol (% predicted)
    • FEV1, % predicted
    • FVC (% predicted)
    • Severity
  • Nocturnal Asthma
  • Non-atopic asthma
  • Nonautoimmune diseases

  • Non-clonal anaemia, press to view attributes;

    • FEV1, % predicted
    • FEV1/FVC
    • FSS (Fatigue Severity Scale)
    • FVC (% predicted)
    • SpO2 (oxygen saturation) %
  • Non-eosinophilic asthma

  • Non-fibrotic lung diseases, press to view attributes;

    • FEV1, % predicted

  • Non-Hodgkin Lymphoma, press to view attributes;

    • B symptoms present
    • Cancer stage (I-IV)
    • Histology type
  • Non-Hodgkin's lymphoma and Hodgkin's lymhoma patients
  • Non-idiopathic pulmonary fibrosis
  • Non-infected ICU patients

  • Non-infection emergency department patients, press to view attributes;

    • % of deaths
    • APACHE IV score
    • CMI (Charlson Comorbidity Index)
    • qSOFA (quick Sequential Organ Failure Assessment)
    • SOFA (Sepsis-related organ failure assessment score)

  • Non-inflammatory neurological diseases (NIND), press to view attributes;

    • Disease duration

  • Non-psoriatic arthritis spondyloarthritis (non-PsA SpA), press to view attributes;

    • Disease duration

  • Non-Small Cell Lung Cancer (NSCLC), press to view attributes;

    • % of deaths
    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Clinical form
    • Clinical outcome
    • Distant metastasis
    • ECOG status
    • EGFR mutation
    • FEV1, % predicted
    • FEV1, L
    • FEV1/FVC
    • Histological grade
    • Histology type
    • Karnofsky performance status
    • KRAS mutation
    • Lymph node metastasis
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • PD-L1 expression
    • Performance status (ECOG/WHO)
    • RECIST
    • T stage of cancer (TNM)
    • Tumor size
  • Non-squamous bronchial carcinoma
  • Non-squamous cell carcinoma of lung
  • Nontoxic multinodular goitre
  • Non-translocation sarcoma
  • Novel coronavirus pneumonia
  • Nummular Eczema
  • Obesity

  • Oesophageal squamous cell cancer, press to view attributes;

    • % of deaths
    • Tumor site/location

  • Optic neuritis, press to view attributes;

    • Disease duration
  • Oral cavity squamous cell carcinoma

  • Oral leukoplakia, press to view attributes;

    • Clinical form
    • Tumor site/location

  • Oral squamous cell carcinoma, press to view attributes;

    • Clinical form
  • Oral submucous fibrosis
  • Oropharyngeal squamous cell carcinoma

  • Osteoarthritis, press to view attributes;

    • Anti-CCP antibody [ACPA] positivity
    • Disease duration
    • KL grade
    • Rheumatoid factor (RF) seropositivity
  • Osteoarthritis inflammatory

  • Osteosarcoma, press to view attributes;

    • Histology type
    • M stage of cancer (TNM)
    • Tumor site/location
    • Tumor size
  • Other inflammatory neurological disorders

  • Other Not Inflammatory Neurological Disorder (ONIND), press to view attributes;

    • Disease duration

  • Ovarian cancer, press to view attributes;

    • % of deaths
    • Cancer stage (I-IV)
    • Histological grade
    • Histology type
  • Ovarian clear cell carcinoma
  • Pancreatic adenocarcinoma

  • Pancreatic cancer, press to view attributes;

    • aSMA H-score
    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Collagen H-Score
    • ECOG status
    • Histological grade
    • Histology type
    • T stage of cancer (TNM)
    • WHO grade
  • Pancreatic ductal adenocarcinoma
  • Paraneoplastic pemphigus
  • Parenchymal neuro-Behçet's syndrome

  • Parkinson disease, press to view attributes;

    • Disease duration
  • Parotid gland acinic cell carcinoma
  • Parotid gland myoepithelioma
  • Parotid gland pleomorphic adenoma
  • Parotid gland Warthin’s tumor

  • Paucigranulocytic asthma, press to view attributes;

    • ACQ-6 score
    • Atopy
    • FEV1 after salbutamol (% predicted)
    • FEV1, % predicted
    • FVC (% predicted)
    • Severity
  • Pemphigus foliaceus

  • Pemphigus vulgaris, press to view attributes;

    • ABSIS
    • Anti-Dsg1 Antibody
    • Anti-Dsg3 Antibody
    • Disease duration
    • Severity
    • Stage

  • Peripheral T-cell lymphoma, press to view attributes;

    • Ann Arbor stage
    • Performance status (ECOG/WHO)
  • Pernicious anemia
  • Pleomorphic adenoma

  • Pneumonia, press to view attributes;

    • FEV1, % predicted

  • Polycystic ovarian syndrome, press to view attributes;

    • HOMA score (Homeostatic model assessment)
  • Polycythaemia
  • Polycythaemia vera
  • pre-B-cell acute lymphoblastic leukemia
  • Prediabetes
  • Preeclampsia
  • Primary angle closure glaucoma
  • Primary biliary cholangitis
  • Primary bronchial carcinoma
  • Primary immune thrombocytopenia
  • Primary progressive multiple sclerosis

  • Primary Sjogren syndrome, press to view attributes;

    • Disease duration
    • ESSDAI
    • ESSPRI
  • Primitive neuroectodermal tumor
  • Progressive supranuclear palsy (PSP)
  • Prostate adenocarcinoma

  • Prostate cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • D'Amico risk group
    • ECOG status
    • Histological grade
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)

  • Psoriasis, press to view attributes;

    • Clinical form
    • Disease duration
    • DLQI
    • IgE specific
    • IgE total
    • Metabolic syndrome (IDF criteria)
    • NAPSI
    • PASI
    • Severity
    • SPARCC
    • Swollen joint count

  • Psoriatic arthritis, press to view attributes;

    • Anti-CCP antibody [ACPA] positivity
    • BASDAI
    • Clinical disease activity index (CDAI)
    • DAPSA
    • DAS28
    • DAS28-ESR
    • Disease duration
    • Joint count
    • MASES
    • PASI
    • Physician Global Assessment (PGA)
    • Radiological score of sacroileitis
    • Rheumatoid factor (RF) seropositivity
    • SDAI
    • SPARCC
    • Swollen joint count
    • Swollen joint count (28-joint score)
    • Tender joint count (28-joint score)
    • VAS-PAIN

  • Pulmonary embolism, press to view attributes;

    • Phase

  • Pulmonary emphysema, press to view attributes;

    • FEV1, % predicted
  • Pure red cell aplasia

  • Pyruvate kinase deficiency anaemia, press to view attributes;

    • TSAT (transferrin saturation)

  • Reactive arthritis, press to view attributes;

    • Anti-ds-DNA positivity
    • Disease duration
    • HLA-B27 seropositivity
  • Recurrent depressive disorders
  • Refractory Bone and Soft Tissue Sarcoma

  • Relapsing polychondritis, press to view attributes;

    • Disease duration
    • Phase
  • Relapsing-remitting multiple sclerosis
  • Renal anemia

  • Renal carcinoma, press to view attributes;

    • Cancer stage (I-IV)
    • Clinical outcome
    • ECOG status
    • Histological grade
    • Histology type
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
    • WHO grade
  • Renal cell carcinoma
  • Renal dysfunction
  • Respiratory syncytial virus (RSV) pneumonia

  • Rheumatoid arthritis, press to view attributes;

    • Anti-CCP antibody [ACPA] positivity
    • Anti-dsDNA
    • Anti-ds-DNA positivity
    • anti-Sm antibodies
    • Anti-SSA
    • Anti-SSB
    • Anti-U1RNP
    • Anti-U1RNP seropositivity
    • Clinical disease activity index (CDAI)
    • DAS28
    • DAS28CRP
    • DAS28-ESR
    • DAS44 score
    • Disease activity
    • Disease duration
    • DLCOc (% predicted)
    • FEV1, % predicted
    • FVC (% predicted)
    • HAQ-DI
    • IgM-Rheumatoid factor seropositivity
    • Larsen grade
    • Larsen score
    • Positivity of anti-SSA/SSB
    • RAI (Ritchie’s articular index)
    • Rheumatoid factor (RF) seropositivity
    • SDAI
    • SF-MPQ (simplified McGill pain questionnaire)
    • Stage
    • Swollen joint count
    • Swollen joint count (28-joint score)
    • Swollen joint count (66-joint score)
    • Tender joint count (28-joint score)
    • Tender joint count (68-joint score)
    • Tender joint count (TJC)
    • TLC (% predicted)

  • Sarcoidosis, press to view attributes;

    • Cancer stage for mixed groups
    • FEV1, % predicted
    • FVC (% predicted)
    • Sarcoidosis stages (chest radiograph stages (Scadding criteria))
    • Stage

  • Sarcoma, press to view attributes;

    • Histological grade
  • SARS-CoV-2 pneumonia

  • Schizophrenia, press to view attributes;

    • Disease duration
    • PANSS

  • Sclerodermia, press to view attributes;

    • Clinical form
    • Disease duration
    • FEV1, % predicted
    • MRSS
  • Sclerosing lymphocytic lobulitis of the breast

  • Seborrheic dermatitis, press to view attributes;

    • SCORAD
  • Seborrheic keratosis
  • Secondary progressive multiple sclerosis

  • Sepsis, press to view attributes;

    • % of deaths
    • APACHE IV score
    • ASA
    • CMI (Charlson Comorbidity Index)
    • MEDS score
    • qSOFA (quick Sequential Organ Failure Assessment)
    • Severity
    • SOFA (Sepsis-related organ failure assessment score)

  • Septic shock, press to view attributes;

    • APACHE II score
    • APACHE III score
    • SAPS II
  • Severe non-allergic eosinophilic asthma
  • Sezary syndrome
  • Sickle cell anemia

  • Sickle cell disease, press to view attributes;

    • TSAT (transferrin saturation)

  • Sjogrens syndrome, press to view attributes;

    • Anti-CCP antibody [ACPA] positivity
    • Anti-dsDNA
    • Anti-ds-DNA positivity
    • Antinuclear antibody (ANA)-positivity
    • anti-Sm antibodies
    • Anti-SSA
    • Anti-SSB
    • Anti-U1RNP
    • Anti-U1RNP seropositivity
    • Disease activity
    • Disease duration
    • ESSPRI
    • Positivity of anti-Sm
    • Positivity of anti-SSA/SSB
    • Rheumatoid factor (RF) seropositivity

  • Skin cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Histology type
    • Localization of the disease
    • Lymph node metastasis
    • T stage of cancer (TNM)
    • Tumor size (cm)
  • Small bowel Crohn's disease

  • Small cell carcinoma of bronchus or lung, press to view attributes;

    • Cancer stage for mixed groups
    • Marburg stage

  • Small cell lung cancer (SCLC), press to view attributes;

    • Cancer stage (I-IV)
    • ECOG status
    • N stage of cancer (TNM)
    • Performance status (ECOG/WHO)
  • Soft tissue sarcoma
  • Solid malignant tumors
  • Solitary fibrous tumor

  • Spinal muscular atrophy, press to view attributes;

    • Disease duration
    • SMA motor score (HMFSE)

  • Spondyloarthritis, press to view attributes;

    • Anti-CCP antibody [ACPA] positivity
    • ASDAS
    • BASDAI
    • Rheumatoid factor (RF) seropositivity

  • Spondyloarthropathy, press to view attributes;

    • Disease duration
    • Swollen joint count (66-joint score)
    • Tender joint count (68-joint score)
  • Sporadic colorectal cancer (SCRC)

  • Squamous cell carcinoma of bronchus or lung, press to view attributes;

    • Cancer stage (I-IV)
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)

  • Squamous cell carcinoma of cervix, press to view attributes;

    • FIGO stage of UCC

  • Squamous cell carcinoma of oesophagus, press to view attributes;

    • Cancer stage (I-IV)
    • Disease duration
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • T stage of cancer (TNM)
  • Squamous cell lung cancer
  • Stable angina
  • Stable coronary artery disease (SCAD)
  • Stat3-Hyper-IgE syndrome
  • STING-associated vasculopathy with onset in infancy (SAVI)
  • Stomach cancer
  • Stress erythrocytosis

  • Stress-induced (Takotsubo) cardiomyopathy, press to view attributes;

    • Phase
  • Subacute thyroiditis
  • Symptomatic cartilage defects
  • Synovial sarcoma
  • System indolent mastocytosis

  • Systemic inflammatory response syndrome (SIRS), press to view attributes;

    • % of deaths
    • MEDS score
  • Systemic juvenile idiopathic arthritis (sJIA)

  • Systemic lupus erythematosus, press to view attributes;

    • ACLA (Anticardiolipin antibody)
    • AECA (anti-endothelial cell antibodies)
    • ANA titer
    • Anti-CCP antibody [ACPA] positivity
    • Anti-dsDNA
    • Anti-ds-DNA positivity
    • Anti-dsDNA/reference anti-dsDNA
    • Anti-La titre
    • Antinuclear antibody (ANA)-positivity
    • anti-RNP
    • Anti-Ro titre
    • anti-Sm antibodies
    • Anti-SSA
    • Anti-SSB
    • Anti-U1RNP
    • Anti-U1RNP seropositivity
    • AnuA (Anti-nucleosome)
    • BILAG
    • c-ANCA
    • Disease activity
    • Disease duration
    • FEV1, % predicted
    • FEV1/FVC
    • FVC (% predicted)
    • GS dose
    • GS dose 2
    • HA IgG ANA positivity
    • IFNGS type
    • Mex-SLEDAI
    • p-ANCA
    • Phase
    • Physician Global Assessment (PGA)
    • Positivity of anti-Sm
    • Positivity of anti-SSA/SSB
    • Rheumatoid factor (RF) seropositivity
    • SDI (SLE Damage Index)
    • SELENA-SLEDAI
    • Severity
    • SLAM (Systemic Lupus Activity Measure)
    • SLE disease activity score [ECLAM]
    • SLEDAI
    • SLEDAI 2K
    • SLICC score
    • Stage
    • TLC (% predicted)
  • Systemic onset juvenile idiopathic arthritis

  • Systemic sclerosis, press to view attributes;

    • % of deaths
    • Anti-CCP antibody [ACPA] positivity
    • Anti-centromere antibodies
    • Anti-dsDNA
    • Anti-ds-DNA positivity
    • Antinuclear antibody (ANA)-positivity
    • Anti-Ro52 antibodies
    • Anti-Scl-70 antibodies
    • anti-Sm antibodies
    • Anti-SSA
    • Anti-SSB
    • Anti-U1RNP
    • Anti-U1RNP seropositivity
    • DAI
    • DSS (disease severity scale)
    • FVC (% predicted)
    • Positivity of anti-SSA/SSB
    • Rheumatoid factor (RF) seropositivity
  • T-cell acute lymphoblastic leukaemia
  • T-cell acute lymphoid leukemia
  • T-cell non-Hodgkin lymphoma

  • Thalassaemia, press to view attributes;

    • HOMA%B
    • HOMA%S
    • HOMA2IR
    • Total iron-binding capacity (TIBC)
    • UIBC
  • Thrombocytopenia
  • Thrombocytosis
  • Thrombosis
  • Thyroid adenoma

  • Thyroid cancer, press to view attributes;

    • Cancer stage (I-IV)
    • Cancer stage for mixed groups
    • Clinical outcome
    • ECOG status
    • Histological grade
    • M stage of cancer (TNM)
    • N stage of cancer (TNM)
    • Severity
    • T stage of cancer (TNM)
  • Thyroid carcinoma

  • Thyroid-associated ophthalmopathy, press to view attributes;

    • Disease duration
  • Tongue squamous cell carcinoma
  • Translocation-associated sarcoma
  • Traumatic ulcers

  • Tuberculosis, press to view attributes;

    • FEV1, % predicted
    • FEV1, L
    • Localization of the disease

  • Type 1 autoimmune pancreatitis, press to view attributes;

    • IgG4-RD RI (Responder Index)

  • Type 1 diabetes, press to view attributes;

    • Disease duration
    • DQOL
    • HbA1c level
  • Type 2 autoimmune pancreatitis

  • Type 2 diabetes, press to view attributes;

    • Disease duration
    • HbA1c level
  • Type II leprosy reaction

  • Ulcerative colitis, press to view attributes;

    • Baron score (endoscopic)
    • Clinical activity index (CAI)
    • Clinical activity index (Mayo)
    • Disease activity
    • Disease duration
    • Disease extent
    • Endoscopic activity score (Mayo)
    • Endoscopic activity score (Rutgeerts)
    • Localization of the disease
    • Montreal Location
    • Phase
    • PUCAI (pediatric ulcerative colitis activity index)
    • Severity
    • Stage

  • Undifferentiated arthritis, press to view attributes;

    • Disease duration
    • Rheumatoid factor (RF) seropositivity

  • Undifferentiated systemic autoinflammatory diseases, press to view attributes;

    • Anti-ds-DNA positivity
    • Rheumatoid factor (RF) seropositivity
  • Unexplained recurrent anaphylaxis
  • Upper gastrointestinal cancers
  • UPS undifferentiated pleomorphic sarcoma
  • Urinary tract infection
  • Urticaria pigmentosa

  • Uterine cervical cancer, press to view attributes;

    • FIGO stage of UCC
    • Lymph node metastasis
    • Tumor differentiation
    • Tumor size
    • Vasoinvasion
  • Uveal melanoma

  • Vascular dementia, press to view attributes;

    • Disease duration
    • Mini Mental State Examination (MMSE)

  • Viral meningitis, press to view attributes;

    • Disease duration
  • Viral meningoencephalitis

  • Wegener’s granuloma, press to view attributes;

    • FEV1, % predicted
  • Well-differentiated liposarcoma
  • X-linked agammaglobulinaemia
  • X-linked severe combined immunodeficiency (SCID-X1)

• 241 tissues/physiological fluids, press to view details;

  • Adenocarcinoma of oesophagus tumor tissue
  • Airway (bronchial) epithelium
  • Airway lamina propria
  • Airway smooth muscle
  • Airways adventitia
  • Airways basement membrane
  • Alveolar wall
  • Arterial serum
  • Ascending colon lamina propria
  • Basement membrane of epidermis
  • Basement membrane of epidermis lesional
  • Basement membrane of epidermis nonlesional
  • Benign lung lesion homogenates
  • Bladder tumor tissue
  • Blood
  • Blood arterial
  • Blood from tumor
  • Bone marrow
  • Bone marrow blood
  • Bone marrow plasma
  • Bone marrow serum
  • Brain metastases stroma
  • Brain tissue
  • Brain tissue lysate (BA21)
  • Breast cancer invasive margin
  • Breast cancer tumor center
  • Breast cancer tumor tissue
  • Breast intra-ductal region
  • Breast intra-lobular region
  • Breast parenchyma
  • Breast peri-ductal region
  • Breast peri-lobular region
  • Breast peri-vascular region
  • Bronchial glands
  • Bronchial mucosa
  • Bronchial subepithelial tissue
  • Bronchial submucosa
  • Bronchial tissue
  • Bronchial wash
  • Bronchoalveolar carcinoma tumor tissue
  • Broncho-alveolar lavage (BAL)
  • Caecum lamina propria
  • Caecum lymphoid aggregates
  • Caecum mucosa
  • Cartilage
  • Cerebrospinal fluid (CSF)
  • Cervical carcinoma tumor tissue
  • Cervical tissue
  • Cervical tumor tissue
  • Cervix adenocarcinoma tumor tissue
  • Cervix squamous cell carcinoma tumor tissue
  • Colon
  • Colon epithelium
  • colon lamina propria lymphoid aggregates/solitary follicles
  • colon lamina propria outside lymphoid aggregates/solitary follicles
  • Colon mucosa
  • Colonic lamina propria
  • Colonic lymphoid follicles
  • Colorectal cancer tumor center
  • Colorectal cancer tumor invasive margin
  • Colorectal cancer tumor tissue
  • Coproextracts
  • Cord blood
  • CTCL tumor tissue
  • Dermis
  • Dermis ISF
  • Dermis papillary
  • Dermis papillary lesional
  • Dermis papillary nonlesional
  • Dermis upper
  • Dermis upper lesional
  • Dermis upper nonlesional
  • Descending colon mucosa
  • Distant metastasis
  • Duodenal lamina propria
  • Duodenal mucosa
  • Endobronchial (airway) biopsies
  • Epidermis
  • Epithelial lining fluid in airways
  • Esophageal cancer tumor tissue
  • Esophageal tumor tissue lysate
  • Exhaled Breath Condensate
  • Gastric mucosa
  • Gastric polyp tissue
  • Gastric tissue
  • Gastric tumor tissue
  • Gastritis tissue
  • Gut-associated lymphoid tissue
  • HCC peritumoral stroma
  • HCC peritumoral tissue
  • Head and Neck Squamous Cell Carcinoma primary tumor
  • Hepatocellular carcinoma tumor tissue
  • Ileal mucosa
  • Ileal mucosa inflamed
  • Ileal mucosa non-inflamed
  • Ileum epithelium
  • Ileum lamina propria
  • Ileum lymphoid aggregates
  • Ileum/Colon mucosa
  • Induced Sputum
  • Inflamed caecum mucosa
  • Inflamed colon mucosa
  • Inflamed colonic lamina propria
  • Inflamed descending colon mucosa
  • Inflamed ileum lamina propria
  • Inflamed intestinal lamina propria
  • Inflamed left flexure mucosa
  • Inflamed rectum mucosa
  • Inflamed right flexure mucosa
  • Inflamed sigmoid colon mucosa
  • Intermediate lymph node
  • Intestinal adventitia
  • Intestinal granulomas
  • Intestinal lamina propria
  • Intestinal lymphoid aggregates
  • Intestinal mucosa
  • Intestinal mucosa lymphoid follicules
  • Intestinal muscular
  • Intestinal submucosa
  • Intratumor soft tissue of synovial sarcoma
  • Intratumoral region of tumor-draining/sentinel lymph node - metastatic
  • Invasive margin of tumor soft tissue of synovial sarcoma
  • Jejunal epithelium
  • Jejunal lamina propria
  • Left flexure mucosa
  • Lesional dermis
  • Lesional dermis ISF
  • Lesional epidermis
  • Lesional skin
  • Liver
  • Liver metastases peritumoral
  • Liver metastasis intratumoral
  • Liver periportal regions
  • Liver: hepatic lobules
  • Liver: portal area
  • Lung adenocarcinoma tumor tissue
  • Lung cancer tissue
  • Lung parenchymal regions
  • Lung tissue
  • Lung vascular/perivascular regions
  • Lymph
  • Lymph node
  • Main lymph node
  • Melanoma peritumoral tissue
  • Melanoma tumor tissue
  • Meninges
  • Mesenteric lymph node
  • Metastasis in distant node
  • Metastasis in liver
  • Metastasis in lung
  • Metastasis in ovary
  • N1 regional lymph nodes
  • N2 regional lymph nodes
  • Nasal lavage
  • Nasal secretion
  • Nasal smears
  • Non-inflamed colon lamina propria
  • Non-inflamed intestinal lamina propria
  • Non-lesional dermis
  • Non-lesional dermis ISF
  • Non-lesional epidermis
  • Non-lesional skin
  • Non-regional lymph nodes
  • Nontumor liver parenchyma
  • NSCLC Intersection of tumor tissue and normal pulmonary tissue
  • NSCLC peritumoral tissue
  • NSCLC tissue (tumor+stroma)
  • NSCLC tumor islets (nests)
  • NSCLC tumor stroma
  • NSCLC tumor tissue
  • NSCLC Tumor tissue homogenate
  • Oesophageal adenocarcinoma tumor centre
  • Oesophageal adenocarcinoma tumor edge
  • oral mucosal transudate (OMT)
  • Ovarian cancer tumor tissue
  • Palatine tonsils
  • Pancreatic cancer stroma
  • Pancreatic tissue
  • Pancreatic tumor tissue
  • Pericardial effusion
  • Peri-intestinal lymph node
  • Peripheral bronchial biopsy specimens
  • Peritoneum
  • Peritumoral region of tumor-draining/sentinel lymph node - metastatic
  • Peyer’s patches
  • Plasma
  • Plasma arterial
  • Plasma from cord blood
  • Pleural effusion
  • Prostate cancer tissue
  • Prostate tissue
  • Rectal lamina propria
  • Rectum mucosa
  • Renal tissue
  • Renal tumor capsula
  • Renal tumor margin
  • Renal tumor stroma
  • Renal tumor tissue
  • Right flexure mucosa
  • Saliva
  • Seeding metastasis
  • Serum
  • Serum from cord blood
  • Serum from tumor
  • Sigmoid colon lamina propria
  • Sigmoid colon mucosa
  • Skin
  • Small intestine
  • Small intestine lamina propria
  • Spleen
  • Sputum
  • Squamos cell carcinoma tumor stroma
  • Squamous cell carcinoma tumor tissue
  • Stratum corneum of epidermis
  • Stratum corneum of lesional epidermis
  • Stratum corneum of non-lesional epidermis
  • Stroma region of colon
  • Suction Blister Fluids
  • Synovial fluid
  • Synovial membrane
  • Synovial membrane intima
  • Synovial membrane subintima
  • Synovial membrane-around lymphocyte clusters
  • Synovial tissue
  • Tears
  • Thyroid adenoma tumor tissue
  • Thyroid carcinoma tumor tissue
  • Thyroid tissue
  • Tonsil tissue
  • Transbronchial (alveolar tissue) biopsies
  • Tumor
  • Tumor adjacent tissue
  • Tumor border zone
  • Tumor center zone
  • Tumor region of colon
  • Tumor-draining/sentinel lymph node
  • Tumor-draining/sentinel lymph node - metastatic
  • Tumor-draining/sentinel lymph node - non-metastatic
  • Tumor-Invaded Lymph Node
  • Urine
  • Vitreous

• 723 molecules (cytokines, chemokines, growth factors, other molecules like PGE2, LTE4 etc), press to view details;

  • 1,2-Diacyl-sn-glycero-3-phosphocholine
  • 12-hydroxyeicosatetraenoic acid (12-HETE)
  • 13,14-dihydro-15-keto Prostaglandin E1 (PGE1)
  • 13,14-Dihydro-15-keto-PGE2
  • 14-HDoHE
  • 15-hydroxyeicosatetraenoic acid (15-HETE)
  • 17-hydroxyprogesterone
  • 25-hydroxyvitamin D (25(OH)D)
  • 5-hydroxyeicosatetraenoic acid (5-HETE)
  • 5'-nucleotidase
  • 6-Keto-Prostaglandin F1α (6-Keto-PGF1α)
  • 8-Epi-prostaglandin F2alpha
  • 8-Hete
  • 8-Hydroxy-2'-deoxyguanosine (8-OHdG)
  • 8-isoprostane
  • 9a,11b-Prostaglandin F2 (9a,11b-PGF2)
  • 9-hydroxy-10E,12Z-octadecadienoic acid
  • A disintegrin and metalloproteinase with thrombospondin motifs 4
  • A disintegrin and metalloproteinase with thrombospondin motifs 5
  • AAT-NE capacity (ANEC)
  • Abeta42
  • Acetylcholine
  • Adenine
  • Adenosine deaminase (ADA)
  • Adenosine Phosphate
  • Adiponectin
  • Adipsin
  • Adrenocorticotropic hormone (ACTH)
  • Advanced glycosylation end product-specific receptor
  • Alanine aminotransferase 1
  • Albumin
  • Albuterol
  • Allantoin
  • Allocystathionine
  • ALP (Alkaline phosphatase)
  • Alpha-1 globulin
  • Alpha-1-acid glycoprotein 1
  • Alpha-1-antichymotrypsin
  • Alpha-1-antitrypsin
  • Alpha-1-antitrypsin polymer
  • Alpha1-fetoprotein transcription factor short variant
  • Alpha-2 globulin
  • Alpha-2-antiplasmin
  • Alpha2-antiplasmin (A2PI)
  • Alpha-2-macroglobulin
  • Alpha-Tocopherol
  • Alprostadil
  • aMCV
  • Amphiregulin
  • Amylase
  • Androstenedione
  • Angiogenin
  • Angiopoietin-1
  • Angiopoietin-2
  • Angiostatin
  • Angiotensin-converting enzyme
  • anti-BP-180
  • anti-BP-230
  • anti-EGFR IgG
  • anti-HBc
  • Anti-HER2 IgA
  • Anti-HER2 IgG
  • Anti-SEA IgE (anti-staphylococcus enterotoxin A)
  • Anti-SEB IgE (anti-staphylococcus enterotoxin B)
  • ApoA-II
  • ApoA-IV
  • ApoB
  • ApoC-II [Apolipoprotein C-II]
  • ApoC-III
  • ApoE
  • Apolipoprotein A-I
  • Appetite-regulating hormone
  • APRIL
  • Arachidonic Acid
  • Arginase-1
  • Arg-Ser
  • Ascorbic acid
  • Aspartate aminotransferase (AST)
  • aspartate transaminase
  • Axl (tyrosine-protein kinase 7)
  • B- and T-lymphocyte attenuator
  • BAFF
  • BAMBI
  • Barbituric Acid
  • Bcl-2
  • Beta-2-microglobulin
  • Betacellulin (BTC)
  • Beta-globulin
  • beta-Hydroxyisovaleric acid
  • b-FGF (basic fibroblast growth factor, FGF2)
  • Bilirubin direct
  • Bilirubin indirect
  • Bilirubin total
  • Blood urea nitrogen
  • Brain natriuretic peptide (BNP)
  • Brain-derived neurotrophic factor (BDNF)
  • C1s inactivator
  • C3 PA (properdin factor B)
  • C3a (Complement component 3a)
  • C3c (Complement component 3c)
  • C3d (Complement component 3d)
  • C4 (Complement component 4)
  • C5a anaphylatoxin chemotactic receptor 1
  • CA 72-4 (cancer antigen 72-4)
  • CA125 (cancer antigen 125)
  • CA12-5 (cancer antigen 12-5)
  • CA15-3 (cancer antigen 15-3)
  • CA19-9 (cancer antigen 19-9)
  • Cadherin-1
  • Calcitonin
  • Carbamide
  • Carcinoembryonic antigen (CEA)
  • Cardiac Troponin I (cTnI)
  • Cathelicidin (LL-37)
  • C-C chemokine receptor type 1
  • C-C motif chemokine 14
  • C-C motif chemokine 18
  • C-C motif chemokine 3
  • cccDNA
  • CCL1 [C-C motif chemokine Ligand 1]
  • CCL11
  • CCL13
  • CCL15
  • CCL16 (HCC-4)
  • CCL17
  • CCL19
  • CCL2
  • CCL20
  • CCL21
  • CCL22
  • CCL23
  • CCL24
  • CCL25
  • CCL26
  • CCL27
  • CCL28
  • CCL3
  • CCL4
  • CCL5 [C-C motif chemokine Ligand 5]
  • CCL7
  • CCL8
  • CCN family member 2
  • CCP (Cyclic Citrullinated Peptide) antibodies
  • CD200 (OX-2) glycoprotein
  • CD40 ligand
  • CGRP [Calcitonin Gene Related Protein]
  • CH50 (Hemolytic Complement 50)
  • Chitinase-3-like protein 1 (YKL-40)
  • Chitotriosidase-1
  • Cholesterol
  • Cholesteryl ester
  • Choline Alfoscerate
  • Cholinesterase (butyrylcholinesterase)
  • ciliary neurotrophic factor (CNTF)
  • Citrate
  • CKMB (creatine kinase isoenzyme)
  • clec9A
  • Collagen alpha-1(I) chain
  • Collagen alpha-1(II) chain
  • Collagen alpha-1(III) chain
  • Collagen alpha-3(IV) chain
  • Complement C1q subcomponent subunit A
  • Complement C1q tumor necrosis factor-related protein 3
  • Complement C1s subcomponent
  • Complement C2
  • Complement C3
  • Complement component C9
  • Complement factor B
  • Coriolic acid
  • C-peptide
  • C-reactive protein (CRP)
  • Creatine kinase
  • Creatinine
  • Cryptoxanthin
  • C-telopeptide
  • CTRP15 (Complement C1q/tumor necrosis factor-related protein 15)
  • CTRP6 (C1q/tumor necrosis factor- α-related protein-6)
  • CX3CL1
  • CXCL1
  • CXCL10
  • CXCL11
  • CXCL12a [C-X-C motif chemokine Ligand 12 alpha]
  • CXCL13
  • CXCL16
  • CXCL2
  • CXCL3
  • CXCL4
  • CXCL5
  • CXCL6
  • CXCL7
  • CXCL9
  • Cyclohexylamine
  • CYFRA 21.1
  • Cystatin C (CysC)
  • Cysteinyl leukotrienes (Cys-LTs)
  • Cytokeratin18 (CK18)
  • Cytotoxic T-lymphocyte protein 4
  • D-dimer (fibrin degradation product)
  • Dehydroepiandrosterone sulfate
  • Desmosine
  • DGLA (dihomo-gamma linolenic acid)
  • DHA (Docosahexaenoic acid)
  • DHEA (dehydroxyepiandrostenedione)
  • Dickkopf-related protein 1
  • Diethanolamine
  • Dihydrothymine
  • Dinoprostone
  • DL-Alanyl-DL-leucine
  • DNA repair nuclease/redox regulator APEX1
  • DPA (Docosapentaenoic acid)
  • E3 ubiquitin-protein ligase MIB1
  • ECP [Eosinophil Cationic Protein]
  • Elafin
  • Elastin-derived peptide
  • EMMPRIN (CD147)
  • Endoglin (CD105)
  • Endostatin
  • Endothelin-1
  • Endotoxin
  • Eosinophil protein Х (EPX)
  • EPA (Eicosapentaenoic acid)
  • Epidermal Growth Factor (EGF)
  • Epinephrine
  • Epiregulin (EPR)
  • ErbB2(CD340, HER-2)
  • Erythroferrone
  • Erythropoietin
  • Estradiol
  • FABP-2
  • FABP4
  • Fatty acid-binding protein, liver
  • Ferritin
  • Fibrin
  • Fibrin Degradation Products (FDP)
  • Fibrinogen
  • Fibrinogen-like protein 1
  • Fibroblast growth factor 1
  • Fibroblast growth factor 2
  • Fibroblast growth factor 21
  • Fibronectin
  • Fibronectin type III domain-containing protein 5
  • FLCs kappa
  • FLCs lambda
  • Flt3‑L
  • Folate
  • Folate receptor beta (FR‐beta)
  • Follicle-stimulating hormone (FSH)
  • Follistatin
  • Follistatin-related protein 1
  • Free Choline
  • Free fatty acid receptor 2
  • Free Fatty acids (FFA)
  • Free Glycerol
  • Free testosterone
  • FT3 (free triiodothyronine)
  • FT4 (free thyroxine)
  • Galectin-1
  • Galectin-3
  • Galectin-9
  • Gamma-globulin
  • gamma-Glutamyl Transpeptidase (GGT)
  • gamma-Glutamylalanine
  • Gamma-tocopherol
  • GCSF [Granulocyte Colony-Stimulating Factor]
  • GDF15
  • GH (growth hormone/somatotropin)
  • GHR (Growth hormone receptor)
  • Glial cell-derived neurotrophic factor (GDNF)
  • Glial fibrillary acidic protein
  • Globulin
  • Glucose
  • Glutamate dehydrogenase 1, mitochondrial
  • Glutamate--cysteine ligase
  • Glutamic Acid
  • Glutathione
  • Glutathione peroxidase 1
  • Glutathione reductase, mitochondrial
  • Glyceric acid
  • Glycoprotein 130 (gp130)
  • Glycyl-proline-dipeptidyl aminopeptidase (GPDA)
  • GMCSF [Granulocyte-Macrophage Colony-Stimulating Factor]
  • Granulysin (GNLY)
  • GranzymeA
  • GranzymeB
  • GRO [Growth-Related Oncogene]
  • Guanosine Monophosphate
  • H2O2
  • Haptoglobin
  • hBD-2 (human β-defensin 2)
  • hBD-3 (human β-defensin 3)
  • HBeAg
  • HB-EGF (Heparin-binding EGF-like growth factor)
  • HBsAg
  • HBV DNA
  • HBV RNA
  • HCV RNA
  • HDL-cholesterol
  • HDL-unesterified cholesterol
  • HE4 (Human epididymis protein 4)
  • Heme oxygenase 1
  • Hemoglobin
  • Hepatitis A virus cellular receptor 1
  • Hepatitis A virus cellular receptor 2
  • Hepatocyte growth factor (HGF)
  • Hepcidin
  • Heptadecanoic acid
  • High mobility group box 1 (HMGB1, amphoterin)
  • high sensitive troponin I (hsTnI)
  • High-sensitivity C-reactive protein (hs-CRP)
  • Hippurate
  • Histamine
  • HIV p24 antigen
  • HIV RNA
  • HNPs (human neutrophil peptides, defensins)
  • Homocysteine
  • HSP-70 (Heat shock protein‑70)
  • Hyaluronan and proteoglycan link protein 1
  • Hydrocortisone
  • ICAM
  • ICAM-1
  • IFNb
  • IFNGR1
  • IgA
  • IgE
  • IGF-1 (insulin growth factor 1)
  • IGFBP-1
  • IGFBP-2 (insulin like growth factor binding protein 2)
  • IGFBP-3
  • IGFBP-4
  • IgG
  • IgG1
  • IgG2
  • IgG3
  • IgG4
  • IgM
  • IL1
  • IL10
  • IL11
  • IL12
  • IL12a (IL12p35)
  • IL12b (IL23p40)
  • IL12p70
  • IL13
  • IL15
  • IL16
  • IL17
  • IL17a
  • IL17af
  • IL17F
  • IL18
  • IL18 BPa
  • IL18BP (Interleukin-18 Binding Protein)
  • IL19
  • IL1a
  • IL1b
  • IL1RAcP
  • IL1RL1 [Interleukin 1 Receptor Like 1]
  • IL2
  • IL20
  • IL21
  • IL22
  • IL23 (p19/p40)
  • IL23p19 (IL23a)
  • IL24
  • IL25
  • IL26
  • IL27
  • IL28a
  • IL29
  • IL2R
  • IL2Ra (sCD25)
  • IL3
  • IL31
  • IL32
  • IL33
  • IL34
  • IL35
  • IL36
  • IL37
  • IL4
  • IL5
  • IL5 Ralpha
  • IL6
  • IL7
  • IL8
  • IL9
  • Immune complexes (IC)
  • Immunoreactive LTC4 (iLTC4)
  • Indole-3-lactic acid
  • Indoleamine 2,3-dioxygenase 1
  • Insulin
  • Intercellular adhesion molecule 5
  • Interferon (IFN)
  • Interferon alpha-1/13
  • Interferon alpha-2
  • Interferon alpha-8
  • Interferon gamma
  • Interferon lambda-2
  • Interferon lambda-3
  • Interleukin-1 family member 10
  • Interleukin-1 receptor accessory protein
  • Interleukin-1 receptor antagonist protein
  • Interleukin-1 receptor type 1
  • Interleukin-1 receptor type 2
  • Interleukin-1 receptor-like 2
  • Interleukin-15 receptor subunit alpha
  • Interleukin-17B
  • Interleukin-17C
  • Interleukin-18 receptor 1
  • Interleukin-2 receptor subunit alpha
  • Interleukin-22 receptor subunit alpha-2
  • Interleukin-36 alpha
  • Interleukin-36 gamma
  • Interleukin-36 receptor antagonist protein
  • Interleukin-4 receptor subunit alpha
  • Interleukin-7 receptor subunit alpha
  • Iron
  • ischemia-modified albumin (IMA)
  • Kallikrein 8
  • Keratin, type I cytoskeletal 19
  • Keratinocyte growth factor
  • Keratocan
  • KL-6
  • Kynurenine
  • Labile plasma iron
  • Lactate
  • Lactate dehydrogenase
  • Lactic Acid
  • Laminin subunit gamma-1
  • Lauric Acid
  • LDL-cholesterol
  • Leptin
  • Leucine
  • Leucine-rich alpha-2-glycoprotein
  • LIF (leukemia inhibitory factor)
  • LIGHT (TNFSF14, CD258)
  • Linoleic Acid
  • Linolenic Acid
  • Lipase
  • Lipocalin-2
  • Lipopolysaccharide-binding protein
  • Lipoxin A4
  • Lp(a) (lipoprotein A)
  • LTB4
  • LTC4
  • LTD4
  • LTE4
  • Luteinizing hormone (LH)
  • Lymphocyte activation gene 3 protein
  • Lymphotoxin-alpha
  • Lysozyme C
  • Macrophage mannose receptor 1
  • Malondialdehyde
  • MAO [Monoamine Oxidase]
  • Mast cell chymase
  • Mast cell tryptase
  • MCSF
  • Melatonin
  • Membrane cofactor protein
  • Meteorin
  • Meteorin-like protein
  • MHC class I polypeptide-related sequence A
  • MHC class I polypeptide-related sequence B
  • Midkine
  • MIF
  • Mitogen-activated protein kinase 1
  • MMP1
  • MMP10
  • MMP12
  • MMP13
  • MMP2
  • MMP7
  • MMP8
  • MMP9
  • M-protein (Myeloma protein)
  • MSPa (macrophage stimulating protein a)
  • MUFA (Monounsaturated Fatty Acids)
  • Myeloblastin
  • Myeloperoxidase (MPO)
  • Myoglobin
  • N-Acetylneuraminic Acid-d3
  • Natriuretic peptides A
  • Nectin-2
  • Neopterin
  • Neurofilament heavy polypeptide
  • Neurofilament light chain
  • Neuron-specifc enolase (NSE)
  • Neuropeptide Y
  • Neurotrophin-3
  • Neurotrophin-4
  • Neutrophil elastase
  • NF-kB
  • NGF [Nerve Growth Factor]
  • NGF-beta (beta-nerve growth factor)
  • Niacinamide
  • Nicotinamide phosphoribosyltransferase
  • NLRP3 (Nod-like receptor protein 3 inflammasome)
  • NO [Nitric Oxide]
  • Non transferrin bound iron
  • Nonesterified Fatty Acid (NEFA)
  • Non-HDL-unesterified cholesterol
  • Non-secretory ribonuclease
  • Norepinephrine
  • Notch-3
  • NT-proBNP (N-terminal brain natriuretic peptide)
  • Oleic Acid
  • Omentin
  • Oncostatin-M
  • ONOO (Peroxynitrite)
  • Osteocalcin
  • Osteopontin (OPN)
  • Oxiglutatione
  • Palmitoleic Acid
  • Parathyroid hormone
  • PARC (recombinant human MIP-4)
  • PC-III (type III pre-collagen)
  • PDGF-AA
  • PDGF-BB [Platelet Derived Growth Factor-BB]
  • Pentraxin-3
  • Perforin
  • Periostin
  • Peroxiredoxin 4 (Prx4)
  • Phenylalanine
  • Phenylalanylphenylalanine
  • Phenylalanylserine
  • Phosphorylcholine Chloride
  • PINP (amino-terminal propeptide of procollagen type I)
  • PIVKA-II
  • Plasminogen
  • Plasminogen activator inhibitor 2 (PAI-2)
  • Plasminogen activator inhibitor-1 (PAI-1)
  • Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1)
  • Platelet-Activating Factor (PAF)
  • Platelet-derived growth factor subunit A
  • Platelet-derived growth factor subunit B
  • Pleiotrophin (PTN)
  • PlGF-1 (Placental growth Factor 1)
  • Poliovirus receptor
  • Prealbumin
  • Presepsin
  • pro-BNP (pro-B-type natriuretic peptide)
  • Procalcitonin
  • Procollagen-3
  • Progastrin‐releasing peptide (ProGRP)
  • Programmed cell death 1 ligand 1
  • Programmed cell death 1 ligand 2
  • Progranulin
  • Prolactin (PRL)
  • Prostaglandin D2 (PGD2)
  • Prostaglandin F2b (PGF2b)
  • Prostaglandin F2α (PGF2α)
  • Prostate-specific antigen
  • Protein carbonyls
  • Protein IL-40
  • Protein S100-A12
  • Protein S100-A4
  • Protein S100-A8
  • Protein S100-A9
  • Protein total
  • Protein-glutamine gamma-glutamyltransferase 2
  • P-tau (phosphorylated tau)
  • PUFA (Polyunsaturated Fatty Acids)
  • Pulmonary surfactant-associated protein A1
  • Pyruvate
  • Renin
  • Resistin
  • Retinoic acid receptor responder protein 2
  • Retinol-binding protein (RBP)
  • Retinol-binding protein 4 (RBP-4)
  • RF (Rheumatoid Factor)
  • RF-IgM
  • RIPK1 (receptor-interacting protein kinase-1)
  • S100A8/A9
  • sAbetaPPbeta
  • sC5b-9
  • sCD14
  • sCD163
  • sCD23
  • sCD27
  • sCD30
  • sCD4
  • sCD8
  • SCFAs (short-chain fatty acids)
  • SCGF-b (Stem Cell Growth Factor beta)
  • sc-kit (SCFR)
  • Sclerostin
  • Secreted frizzled-related protein 2
  • Secreted frizzled-related protein 3
  • Secretory Leukocyte Protease Inhibitor (SLPI)
  • sEGFR (Soluble epidermal growth factor receptor)
  • Selenium
  • Serpin B3
  • Serum amyloid A
  • sE-selectin (CD62E)
  • SFA (Saturated Fatty Acids)
  • Sgp130 (Soluble Glycoprotein 130)
  • Sialic acid-binding Ig-like lectin 5
  • Sialic acid-binding Ig-like lectin 7
  • Sialic acid-binding Ig-like lectin 9
  • Signal transducer and activator of transcription 3
  • sIL1R4 (Soluble Interleukin-1 Receptor-4)
  • sIL2R
  • sIL6R
  • sIL6Ra
  • sILT3
  • SLAMF8
  • sLLT1
  • sL-selectin
  • sNOX2dp
  • Soluble transferrin receptor (sTfR)
  • SP-40,40 (clusterin)
  • SPARC
  • sPD-1
  • Sphingomyelin
  • S-protein (vitronectin)
  • sP-selectin
  • sST2 (Soluble suppression of tumorigenicity-2)
  • Stearic Acid
  • Stem Cell Factor (SCF)
  • sTIE-2 (soluble angiopoietin receptor 2)
  • sTNF-R1
  • sTNF-R2
  • sTREM2 (soluble triggering receptor expressed on myeloid cells 2)
  • Stromal cell-derived factor 1
  • Stromelysin-1
  • Substance P (SP)
  • SuperOxide Dismutase (SOD)
  • Suppressor of cytokine signaling 1
  • Suppressor of cytokine signaling 3
  • Surfactant protein D (SP-D)
  • sVEGFR1
  • sVEGFR2
  • Syndecan-1
  • Syndecan-2
  • Taurine
  • T-cell-specific surface glycoprotein CD28
  • Tenascin C
  • TgAb (thyroglobulin antibodies)
  • TGFa
  • TGFb
  • TGF-beta receptor type-1
  • TGF-beta receptor type-2
  • Thioredoxin 1 (TRX1)
  • Thrombin-antithrombin complex (TAT)
  • Thrombomodulin
  • Thrombopoietin (TPO, MGDF)
  • Thrombospondin-1
  • Thrombospondin-2 (THBS2)
  • Thromboxane B2 (TXB2)
  • Thr-Phe
  • Thyroglobulin (TG)
  • TIMP1
  • TIMP2
  • TIMP3
  • TIMP4
  • Tissue factor
  • Tissue factor pathway inhibitor
  • Tissue Plasminogen Activator (tPA)
  • Tissue plasminogen activator (tPA)/plasminogen activator inhibitor type I (PAI) complex (tPA/PAI)
  • TL1A (TNFSF15)
  • T-lymphocyte activation antigen CD80
  • T-lymphocyte activation antigen CD86
  • TNFR1
  • TNFRSF19L
  • TNTHSST (high-sensitivity troponin T)
  • Toll-like receptor 2
  • Total bile acid (TBA)
  • Total cholesterol
  • Total testosterone
  • TPOAb (Thyroid peroxidase antibody)
  • TRAb (thyrotropin receptor autoantibody)
  • TRAIL (TNF-related apoptosis-inducing ligand)
  • TRAIL R1
  • Transferrin
  • Transforming growth factor beta-1 proprotein
  • Transforming growth factor beta-2 proprotein
  • Transforming growth factor beta-3 proprotein
  • Transthyretin
  • Triggering receptor expressed on myeloid cells 1
  • Triglyceride
  • Triglycerides
  • Troponin
  • Troponin I
  • Troponin T
  • Tryptase
  • TSH (thyroid-stimulating hormone)
  • TSLP
  • T-tau (total tau)
  • Tumor necrosis factor
  • Tumor necrosis factor alpha-induced protein 8
  • Tumor necrosis factor ligand superfamily member 11
  • Tumor necrosis factor ligand superfamily member 6
  • Tumor necrosis factor receptor superfamily member 11A
  • Tumor necrosis factor receptor superfamily member 11B
  • Tumor necrosis factor receptor superfamily member 18
  • Tumor necrosis factor receptor superfamily member 5
  • Tumor necrosis factor receptor superfamily member 6
  • Tumor necrosis factor receptor superfamily member 9
  • TWEAK
  • Type II procollagen gene
  • Tyramine
  • Unesterified cholesterol
  • Urate
  • Urokinase plasminogen activator surface receptor
  • Urokinase-type plasminogen activator (uPA)
  • VAP-1 (vascular adhesion protein-1)
  • VCAM-1 (vascular cell adhesion molecule-1)
  • VEGF [Vascular Endothelial Growth Factor]
  • VEGF-A
  • VEGF-C
  • VEGF-D
  • VIP [Vasoactive Intestinal Peptide]
  • Vitamin A
  • Vitamin B12
  • Vitamin B6
  • Vitamin D-binding protein
  • VLDL
  • von Willebrand factor
  • V-set domain-containing T-cell activation inhibitor 1
  • Xanthine
  • XCL1
  • α-hydroxybutyrate dehydrogenase (α-HBDH)
  • α-L-fucosidase

• 272 cell types and states, press to view details;

  • Activated B-cells
  • activated circulating endothelial cells (aCECs)
  • Activated Eosinophils
  • Activated memory Tc-cells
  • Activated Memory T-cells
  • Activated memory Th-cells
  • Activated Monocytes
  • Activated NK-cells
  • Activated suppressor T cells
  • Activated Tc-cells
  • Activated T-cells
  • Activated Tfh-cells
  • Activated Th1
  • Activated Th17-cells
  • Activated Th-cells
  • Activated Treg-cells
  • Activated switched memory B-cells
  • Age-associated-like B-cells
  • alpha-beta T-cells
  • Antigen Presenting Cell (APC)
  • Apoptotic cells
  • Atypical activated memory cells
  • Atypical memory B-cells
  • B10 cells
  • Basophils
  • B-cells
  • Blast cells
  • Bm1-cells
  • Bm2-cells
  • Bm3-cells
  • Bm4-cells
  • Bm5 Early cells
  • Bm5 Late cells
  • Breg cells
  • Cells
  • Central memory DN Th17-cells
  • Central memory DP Th17-cells
  • Central memory Tc-cells
  • Central memory T-cells
  • Central memory Tfh-cells
  • Central memory Th17.1-cells
  • Central memory Th17-cells
  • Central memory Th1-cells
  • Central memory Th2-cells
  • Central memory Th-cells
  • Circulating endothelial cells
  • Circulating endothelial progenitor cells (EPCs)
  • Circulating progenitor cells (CPCs)
  • Circulating tumor cells (CTCs)
  • Classical DC1
  • Classical DC2
  • classical Th17-like
  • Class-swiched B-cells
  • class-switched memory B cells
  • Clonal B-cells
  • Columnar epithelial cells
  • DC (Dendritic Cells)
  • Dermal dendritic cells
  • Double negative memory B-cells
  • Double negative Th17
  • Double positive B-cells
  • Double positive T cells (DP T cells)
  • Double positive Tfh
  • Double positive Th17
  • Double-Negative B-cells
  • Double-negative T cells
  • Double-Positive (DP) memory Th-cells
  • Dual-TCR-Treg-cells
  • Early effector memory Tc-cells
  • Early effector memory Th-cells
  • Early T-cells
  • Effector memory B-cells
  • Effector memory DN Th17-cells
  • Effector memory DP Tfh-cells
  • Effector memory DP Th17-cells
  • Effector memory Tc-cells
  • Effector memory T-cells
  • Effector memory Tfh17-cells
  • Effector memory Tfh1-cells
  • Effector memory Tfh2-cells
  • Effector memory Tfh-cells
  • Effector memory Th17.1-cells
  • Effector memory Th2-cells
  • Effector memory Th-cells
  • Effector Tc-cells
  • Effector T-cells
  • Effector Th-cells
  • Effector Treg cells
  • e-MDSC (early stage MDSC)
  • Eosinophil
  • Epidermal cells
  • Epithelial cells
  • Erythroblasts
  • Erythroid cells (CECs)
  • Exhausted T-cells
  • Fibroblast-like synoviocytes
  • Fibrocytes
  • Follicular Treg cells (Tfr)
  • Functional T-cells
  • gamma-delta T17-cells
  • gamma-delta T-cells
  • Germinal Center B-cells
  • Giant platelets
  • G-MDSC [Granulocytic Myeloid-Derived Suppressor Cells]
  • Hepatocytes
  • Histiocytes
  • IDEC (Inflammatory Dendritic Epidermal Cells)
  • IDEC/IDDC
  • ILC2 (Innate lymphoid cells 2)
  • Immature B cells
  • Immature granulocytes
  • Immature platelets
  • Immature T-cells
  • Immature transitional B cells
  • Immune cells
  • Immunocytes(T-cells,B-cells,Mast cells)
  • Induced regulatory T cells
  • iNKT cells
  • Intermediate T-cells
  • Invariant natural killer T-cell
  • Kupffer cells
  • Langerhans Cells (LC)
  • Late effector memory Tc-cells
  • Late effector memory Th-cells
  • Late memory Tc-cells
  • Late T-cells
  • Lymph node-resident Dendritic cell (LNDC)
  • Lymphocytes
  • M2a-macrophages
  • M2b-macrophages
  • M2c-macrophages
  • Macrophages
  • Mast cells
  • Mast cells progenitor
  • Mature B cells
  • Mature Dendritic Cells (DC)
  • Mature Langerhans cells
  • Mature naive B cells
  • Mature NK-cells
  • mDC [Myeloid Dendritic Cells]
  • Megakaryocytes
  • Memory B-cells
  • Memory regulatory T-cells
  • Memory Tc-cells
  • Memory T-cells
  • memory Th17.1-cells
  • memory Th17-cells
  • Memory Th1-cell
  • memory Th22-cells
  • memory Th2-cells
  • memory Th-cells
  • Memory Treg-cells
  • Metachromatic cells (mast cells and basophils)
  • M-MDSC [Monocytic Myeloid-Derived Suppressor Cells]
  • Monocytes
  • Monocytes/macrophages
  • Mononuclear cells
  • Myeloid cells
  • Myeloid Dendritic Cells 1 (mDC1)
  • Myeloid Dendritic Cells 2 (mDC2)
  • Myeloid-Derived Suppressor Cells (MDSC)
  • Naive B-cells
  • Naive regulatory B-cells
  • Naive regulatory T-cells
  • Naive suppressor T cells
  • Naive Tc-cells
  • Naive T-cells
  • Naive Th1
  • Naive Th-cells
  • Naive Treg-cells
  • Natural Effector B-cells
  • Natural killer T-cells
  • Neutrophil
  • Neutrophil total
  • Neutrophils Nonsegmented
  • Neutrophils Segmented
  • New memory B cells
  • NK (Natural Killer cells)
  • NK1
  • NKT [Natural Killer-like T-cells]
  • Non-memory B cells
  • Nonsuppressive Treg-cells
  • Non-switched B cells
  • Non‐switched memory B-cells
  • Non-Treg memory T-cells
  • non-Treg-cells
  • nucleated RBCs
  • Pan-leukocytes
  • PBMC (Lymphocytes and Monocytes)
  • PD-L1+ Cell
  • Peripheral blood monocytes
  • Plasma B-cells
  • Plasmablasts
  • Plasmacytoid Dendritic Cells (pDC)
  • Platelets
  • PMN-MDSCs [Mononuclear Myeloid-Derived Suppressor Cell]
  • Polyclonal B-cells
  • Polymorphonuclear (PMN) leukocytes
  • Post-switched memory B cells
  • Precursor neutrophils
  • Precursor of Germinal Center B-cells
  • Pre-naive B-cells
  • Pre-switched memory B cells
  • Primarily memory B cells
  • Progranulocytes
  • Prolymphocytes
  • Red blood cells
  • resting circulating endothelial cells (rCECs)
  • Resting class-switched memory B-cells
  • Resting neutrophils
  • Resting Treg-cells
  • Reticulated siderocytes
  • Reticulocyte
  • Ring sideroblasts
  • RTE-Treg-cells
  • Sezary cells
  • Siderocytes
  • Squamous cells
  • Stem Cell Memory T cell (Tscm)
  • sTreg-cells
  • Stromal cells
  • Suppressor T cells
  • Suppressor T-lymphocytes
  • Switch precursor B-cells
  • Switched memory B-cells
  • T1 Transitional B cells
  • T2 Transitional B cells
  • Tang-cells (angiogenic)
  • Tc10-cells
  • Tc17.1-cells
  • Tc17-cells
  • Tc1-cells
  • Tc21-cells
  • Tc22-cells
  • Tc2-cells
  • Tc9-cells
  • Tc-cells
  • T-cells
  • Tconv-cells
  • Tcreg-cells
  • TD-T-cells (Terminally differentiated effector T cells)
  • TEMRA (Terminally differentiated effector memory T cells)
  • TEMRA Tc-cells
  • TEMRA Th-cells
  • Terminal effector T-cells
  • Terminal memory Th-cells
  • Tfc-cells (follicular cytotoxic T-cells)
  • Tfh1.17-cells
  • Tfh17.1-cells
  • Tfh17-cells
  • Tfh1-cells
  • Tfh2-cells
  • Tfh-cells (follicular helper T-cells)
  • Th0-cells
  • Th17.1-cells
  • Th17-cells
  • Th1-cells
  • Th22-cells
  • Th2-cells
  • Th9-cells
  • Th-cells
  • Th-cells exhausted
  • T-helper lymphocytes
  • TIP-DC (TNF and iNOS-producing dendritic cell)
  • Total cell count
  • Tph-cells (peripheral helper T-cells)
  • Transitional B cells
  • Transitional memory T-cells
  • Treg-cells
  • Trm-cells (tissue-resident memory T cells)
  • Unswitched memory B-cells
  • White Blood Cells (WBC)

• 682 cell markers, press to view details;

  • _No markers_
  • 5HT1AR+
  • 5HT2AR+
  • AA1+
  • AAT+
  • a-GalCer/CD1d tetramer+
  • ALDH+
  • alpha/beta-TCR+
  • Annexin V+
  • arginase-1+
  • B7-Н3+
  • bcl2+
  • Bcl6+
  • BDCA1+
  • BDCA2+
  • BDCA3+
  • BDCA4+
  • BDNF+
  • BLIMP-1low
  • BR3+
  • BTLA+
  • C3 receptor (CRL)+
  • C38++
  • CCL1+ (I-309+)
  • CCL17+ (TARC+)
  • CCL22+ (MDC+)
  • CCR1+
  • CCR10-
  • CCR10+
  • CCR2+ (CD192+)
  • CCR3+
  • CCR4-(CD194-)
  • CCR4-/+(CD194-/+)
  • CCR4+(CD194+)
  • CCR4neg
  • CCR5-(CD195-)
  • CCR5(CD195)int
  • CCR5+(CD195+)
  • CCR6-(CD196-)
  • CCR6-/+(CD196-/+)
  • CCR6+(CD196+)
  • CCR6neg
  • CCR7(CD197)-
  • CCR7(CD197)+
  • CCR8+
  • CCR9+
  • CD1+
  • CD10-
  • CD10+
  • CD101+
  • CD103-
  • CD103+
  • CD105-
  • CD105+
  • CD106-
  • CD106+
  • CD107+
  • CD107a+ (LAMP-1)
  • CD112+
  • CD117+
  • CD11a+
  • CD11b-
  • CD11b high
  • CD11b+
  • CD11c-
  • CD11c_hi
  • CD11c_int
  • CD11c_low
  • CD11c+
  • CD12+
  • CD122 (IL2Rb)+
  • CD123-
  • CD123+
  • CD123dim
  • CD123high
  • CD123inter
  • CD123low
  • CD124 (IL4RA)+
  • CD126 (IL6Ra)+
  • CD127-
  • CD127-/dim
  • CD127+
  • CD127low
  • CD127low/-
  • CD13+
  • CD132 (IL2RG)+
  • CD133-
  • CD133+
  • CD134+ (OX40+)
  • CD137+ (4-1BB)
  • CD138-
  • CD138-/+
  • CD138+
  • CD14-
  • CD14 Bright
  • CD14-/low
  • CD14+
  • CD14++
  • CD141-(BDCA3-)
  • CD141+ (BDCA3+)
  • CD144+
  • CD146-
  • CD146(MCAM)+
  • CD14dim
  • CD14hi
  • CD14low
  • CD15-
  • CD15+
  • CD152+
  • CD154+
  • CD155+
  • CD158a+
  • CD158b+
  • CD158b1+ (p58.2+)
  • CD158e+ (p70+)
  • CD158h+
  • CD158j+
  • CD158k+ (p140+)
  • CD15high
  • CD16-
  • CD16+
  • CD16++
  • CD161-
  • CD161+
  • CD161bright
  • CD161hi
  • CD162+ (PSGL1)
  • CD163-
  • CD163+
  • CD163dim
  • CD163high
  • CD163low
  • CD166(ALCAM)+
  • CD169-
  • CD169+
  • CD169high
  • CD169low
  • CD16b- (FcgRIIIb-)
  • CD16bright
  • CD16dim
  • CD16high
  • CD16neg
  • CD16neg/dim
  • CD16pos
  • CD18+
  • CD183-
  • CD183+ (CXCR3)
  • CD19-
  • CD19+
  • CD196-
  • CD196+
  • CD19low
  • CD1a-
  • CD1a_hi
  • CD1a_int
  • CD1a+
  • CD1b/c+
  • CD1b+
  • CD1c-
  • CD1c+ (BDCA1+)
  • CD1d high
  • CD1d+
  • CD2+
  • CD20-
  • CD20+
  • CD205+
  • CD206+
  • CD206+ (MMR+)
  • CD206+/high
  • CD206+/low
  • CD209+(DC-SIGN)
  • CD20dim
  • CD20low
  • CD21-
  • CD21+
  • CD212+ (IL-12R-b2)
  • CD21low
  • CD21neg/lo
  • CD22+
  • CD226-
  • CD226+
  • CD23-
  • CD23+
  • CD24-
  • CD24 low
  • CD24+
  • CD24++
  • CD243-
  • CD243+
  • CD244(2B4,SLAMF4)+
  • CD24high
  • CD24int
  • CD25- (IL-2Rα-)
  • CD25-/+ (IL-2Rα-/+)
  • CD25+ (IL-2Rα+)
  • CD25+/high (IL-2Rα+/high)
  • CD25++ (IL-2Rα++)
  • CD25+++ (IL-2Rα+++)
  • CD25bright (IL-2Rα bright)
  • CD25dim
  • CD25high (IL-2Rα high)
  • CD25int
  • CD25low
  • CD25low/- (IL-2Rα low/-)
  • CD25med
  • CD25neg
  • CD26-
  • CD26+
  • CD267+ (TNFRSF13B+, TACI+)
  • CD268+ (BAFF-R+, TNFRSF13C+)
  • CD269+ (BCMA+, TNFRSF13B+, TNFRSF17+)
  • CD26high
  • CD27-
  • CD27+
  • CD27+/-
  • CD27++
  • CD274+
  • CD279+
  • CD27BR
  • CD27hi
  • CD28-
  • CD28+
  • CD28+/-
  • CD282+ (TLR2+)
  • CD284+ (TLR4+)
  • CD29(integrin beta1)+
  • CD29(integrin beta1)high
  • CD3-
  • CD3+
  • CD30(TNFRSF8)+
  • CD300e-
  • CD300e+
  • CD301+
  • CD303- (BDCA2-)
  • CD303+ (BDCA2+)
  • CD304- (BDCA4-,Nrp1-)
  • CD304+ (BDCA4+,Nrp1+)
  • CD31+
  • CD314(NKG2D)-
  • CD314(NKG2D)+
  • CD319(SLAMF7)+
  • CD32-
  • CD33+
  • CD33hi
  • CD33inter
  • CD33neg/dim
  • CD34+
  • CD352(NTBA,SLAMF6)+
  • CD36+
  • CD38-
  • CD38-/+
  • CD38-/lo
  • CD38+
  • CD38+/-
  • CD38++
  • CD38BR
  • CD38dim
  • CD38high
  • CD38int
  • CD38low
  • CD38low/-
  • CD38neg
  • CD39+
  • CD3e-
  • CD3e+
  • CD4-
  • CD4+
  • CD4+/-
  • CD40+
  • CD40L+
  • CD43+
  • CD44+
  • CD45-
  • CD45-/dim
  • CD45+
  • CD45bright
  • CD45dim
  • CD45hi
  • CD45int/bright
  • CD45R-
  • CD45R+
  • CD45RA-
  • CD45RA high
  • CD45RA low
  • CD45RA+
  • CD45RA+/-
  • CD45RAbright
  • CD45RAneg
  • CD45RBhigh
  • CD45RBlow
  • CD45RO-
  • CD45RO+
  • CD45RO++
  • CD45ROhigh
  • CD45ROlow
  • CD45ROMed
  • CD48+
  • CD49a+
  • CD49d-
  • CD49d high (VLA4 high)
  • CD49d+
  • CD49e+
  • CD4dim
  • CD4hi
  • CD4lo
  • CD5-
  • CD5+
  • CD5+/-
  • CD54+
  • CD55+
  • CD56-
  • CD56+
  • CD56bright
  • CD56dim
  • CD56hi
  • CD56int
  • CD56low
  • CD57+
  • CD59+
  • CD6+
  • CD62L-
  • CD62L+ (L-selectin)
  • CD62L+/- (L-selectin)
  • CD62Llow
  • CD63+
  • CD64-
  • CD64(FcgRI)+
  • CD66+
  • CD66b- (CEACAM8-)
  • CD66b high
  • CD66b+
  • CD68-
  • CD68+
  • CD69-
  • CD69+
  • CD7-
  • CD7+
  • CD70+
  • CD71+
  • CD73-
  • CD73+
  • CD74
  • CD77-
  • CD77+
  • CD78+
  • CD79+
  • CD8-
  • CD8+
  • CD80+
  • CD83-
  • CD83+
  • CD85j (ILT2)+
  • CD86+
  • CD8bright
  • CD8hi
  • CD8lo
  • CD94+
  • CD95-
  • CD95(FasR)+
  • CD95+/-
  • CD95high
  • CD95Low/Med
  • CD95Med
  • CD96+
  • CFSE-
  • CK-
  • CK+
  • CLA-
  • CLA+
  • CRTH2(CD294)+
  • CTLA-4-
  • CTLA-4_Intracellular+
  • CTLA-4_Surface+
  • CTLA-4+
  • CX3CR1+
  • CXCL13+
  • CXCL8+(IL8+)
  • CXCR1+
  • CXCR2+
  • CXCR3-(CD183-)
  • CXCR3-/+(CD183-/+)
  • CXCR3+(CD183+)
  • CXCR3hi(CD183hi)
  • CXCR3neg
  • CXCR4+
  • CXCR5-(CD185-)
  • CXCR5+(CD185+)
  • CXCR5hi/int(CD185hi/int)
  • CXCR6(CD186)-
  • CXCR7+
  • DC-LAMP+
  • DR+
  • DR3+
  • EB6+
  • E-cadherin+
  • ECP+
  • EG1+
  • EG2+
  • Elastase+
  • Eomes_hi
  • Eomes+
  • eotaxin+
  • Epcam+
  • EZH2-
  • EZH2+
  • Fas-
  • FasL (CD95L/CD178)
  • FceRI+
  • FceRII+
  • FcRL4+
  • FcRL5+
  • fHOBIThigh
  • FMC7+
  • FOXP3-
  • FOXP3+
  • FoxP3dim
  • FoxP3high
  • FoxP3Int
  • FoxP3low
  • FSC_high
  • FSC_im
  • FSC_low
  • gamma/delta-TCR-
  • gamma-delta-TCR+
  • gammaTCS1+
  • gammaV1+
  • gammaV2+
  • GARP+
  • Gata-3+
  • GITR+
  • gl183+
  • GM-CSF+
  • GM-CSFR+
  • GPA(CD235a)+
  • GranzymeA-
  • GranzymeA+
  • GranzymeB-
  • GranzymeB+
  • GranzymeK+
  • GranzymeM+
  • GZMB+
  • HBcAg-specific+
  • HBsAg-specific+
  • Helios+
  • HLA-ABC+
  • HLA-DR-
  • HLA-DR-/low
  • HLA-DR+
  • HLA-DR+/-
  • HLA-DRdim
  • HLA-DRhigh
  • HLA-DRint
  • HLA-DRlow
  • HMGB1-
  • HNK-1+
  • ICOS+
  • ICOShigh
  • ICOSL+
  • ICOSLhi
  • IDO+
  • IFNa+
  • IFNb+
  • IFNg-
  • IFNg+
  • IgA+
  • IgD-
  • IgD high
  • IgD low
  • IgD+
  • IgD++
  • IgE+
  • IgG-
  • IgG+
  • IgG4+
  • IgM-
  • IgM high
  • IgM low/int
  • IgM+
  • IgM+/-
  • IgM++
  • IL10-
  • IL10+
  • IL10R+
  • IL10Ra+
  • IL10Rb+
  • IL11+
  • IL11Ra+
  • IL12+
  • IL12p70+
  • IL13+
  • IL15+
  • IL15Ra(CD215)+
  • IL17-
  • IL17+
  • IL17a-
  • IL17a+
  • IL17F+
  • IL17RC
  • IL18+
  • IL18R+
  • IL18Ra+
  • IL1R1+
  • IL2-
  • IL2+
  • IL20R1+
  • IL21+
  • IL21R
  • IL22-
  • IL22+
  • IL22R+
  • IL23p19+
  • IL23R+
  • IL25+
  • IL2R+
  • IL33+
  • IL35+
  • IL36R+
  • IL37+
  • IL4-
  • IL4+
  • IL5+
  • IL6+
  • IL6R+
  • IL7Ra high
  • IL7Ra low
  • IL7Ra+
  • IL9+
  • ILT3high
  • iNOS+
  • Integrin alpha4 beta7 (LPAM-1)-
  • Integrin alpha4 beta7 (LPAM-1)+
  • Integrin beta7+
  • IP-10(CXCL10)+
  • I-TAC(CXCL11)+
  • Ki67-
  • Ki67+
  • KLRG1+
  • LAG3-
  • LAG3+
  • Langerin+ (CD207+)
  • LAP+
  • Lin-
  • Lin- (CD3-, CD19-, CD56-)
  • Lin1-
  • Lin1low/-
  • LLT1+
  • MAC387+
  • Mast Cell Chimase+ (MCC+)
  • Mast Cells Tryptase+ (MCT+)
  • MBP+
  • Melan-A tetramer+
  • MHC-I+
  • MHCII+ (HLAII+)
  • MMP12+
  • MPO+ (myeloperoxidase+)
  • MRP8-
  • MRP8+
  • MUM+
  • MUM1+
  • Neutrophil elastase+
  • NGF+
  • NKB1+
  • NKG2A
  • NKG2C+(KLRC2,CD159c)
  • NKp30
  • NKp44
  • NKp46
  • normal ratio kappa/lambda
  • NT3+
  • NY-ISO-1
  • OX40+
  • OX40L+
  • p53+
  • p75+ (AIRM-1+)
  • PAS+
  • PAX
  • PCA-1
  • PCNA+
  • PD-1(CD279)-
  • PD-1+
  • PD-1++(high)
  • PD-1low
  • PD-L1-
  • PD-L1+(B7-H1+)
  • PD-L1hi
  • PD-L1int
  • PD-L1low
  • Perforin-
  • Perforin+
  • polyAAT+
  • PRF1+
  • pSTAT3+
  • PTK7+
  • restriction kappa/lambda
  • RORc+
  • RORgt+
  • RUNX3+
  • S6F1+
  • S-AF647+
  • S-BV421+
  • SERT+
  • SIRPa+(CD172A+)
  • SLAMF1(CD150)+
  • SLAMF3(CD229+)
  • SLAMF5(CD84)+
  • SOCS3+
  • SSC_high
  • SSC_im
  • SSC_low
  • SSC_med
  • SSCint
  • T-bet_dim
  • T-bet_hi
  • T-bet_int
  • T-bet_lo
  • T-bet+
  • TCF1+
  • TCR-zeta bright
  • TCR-zeta dim
  • TCR-zeta int
  • TGFb-
  • TGFb+
  • TIGIT-
  • TIGIT+
  • TIM3+
  • Tissue Factor+ (TF+)
  • TLR3+
  • TLR4+
  • TLR7+
  • TLR9+
  • TNFa-
  • TNFa hi
  • TNFa low
  • TNFa+
  • TNFR2(TNFRSF1B)+
  • TOX+
  • TR+(Transferrin receptor)
  • TRAIL+
  • Tryptase+
  • TSLP+
  • UCHL1+
  • Va12+
  • Va2+
  • Va24+
  • Va24-Ja18(6B11)+
  • Va7.2+
  • vb1+
  • Vb11+
  • Vb12+
  • vb13.1+
  • vb13.2+
  • vb13.6+
  • Vb13+
  • vb14+
  • vb16+
  • vb17+
  • vb18+
  • Vb2+
  • vb20+
  • vb21.3+
  • vb21+
  • vb22+
  • vb23+
  • Vb3+
  • Vb4+
  • vb5.1+
  • Vb5.2+
  • Vb5.3+
  • Vb6.1+
  • vb7.1+
  • vb7.2+
  • Vb8+
  • Vb9+
  • Vd1+
  • Vd2-
  • Vd2+
  • VEGFR2(KDR)+
  • Vg9+
  • VLA1+(integrin-a1b1)
  • ZAP-70 bright
  • ZAP-70 dim
  • ZAP-70 int
• 96870 values of cytokine/cell concentrations;
• data extracted from 2588 papers/other public sources.

CYTOCON API:

• OPENAPI CYTOCON DB
• The API description of the DB allows access to CYTOCON DB